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Owing to their unique mechanical, electrical, optical, and thermal properties, carbon nanostructures including carbon nanotubes
and graphenes show great promise for advancing the fields of biology and medicine. Many reports have demonstrated the promise
of these carbon nanostructures and their hybrid structures (composites with polymers, ceramics, and metal nanoparticles, etc.) for
a variety of biomedical areas ranging from biosensing, drug delivery, and diagnostics, to cancer treatment, tissue engineering, and
bioterrorism prevention. However, the issue of the safety and toxicity of these carbon nanostructures, which is vital to their use as
diagnostic and therapeutic tools in biomedical fields, has not been completely resolved. This paper aims to provide a summary of
the features of carbon nanotube and graphene-based materials and current research progress in biomedical applications. We also
highlight the current opinions within the scientific community on the toxicity and safety of these carbon structures.
1. Introduction
Carbon nanotubes (CNTs) and graphene are very promising
candidates to form the basis of new biological and medical
devices. Carbon nanotubes can be thought of as rolled-
up graphene sheets with no overlapping edges [1]. Their
diameters typically vary from 1 to 100 nm and their lengths
can be several orders of magnitude larger, up to millimeters,
even centimeters long [2]. Various orientations of CNTs are
shown in Figures 1(a)–1(c): randomly oriented, vertically
aligned, and in a “dandelion-like” structure, respectively.
The well-documented beneficial mechanical, electrical and
chemical characteristics of CNTs and graphene [1, 3–7] as
well as their ability to be hybridized with a wide range of
organic and inorganic materials make them ideal candidates
for many biomedical applications such as biosensing [8–12],
tissue engineering [13–15], and drug delivery [16, 17].
In the past two decades, intense eﬀorts have been direct-
ed at providing specificity, selectivity, reproducibility, and
robustness to these carbon nanostructures in biologically rel-
evant environments [18–22]. However, the issue of toxicity
of CNTs and graphene in living biological systems, which
is vital for the successful incorporation of these materials
into functional biomedical devices, remains unsolved at
macroscopic, cellular, and intracellular levels [23–25].
In this paper we will, in Section 2, discuss the role of
CNTs in biosensing, tissue engineering, and drug delivery.
Aspects of the toxicity of CNTs in living biological systems
are then discussed in Section 3 and the emerging graphene-
related biomedical applications and associated safety issues
are briefly presented in Section 4. Finally, a summary of this
work and an outlook for future research is provided.
2. Applications of Carbon
Nanotubes in Biomedicine
Due to the chemical inertness of graphitic walls, functional-
ization of CNTs and graphene is often the key step required in
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Figure 1: Various orientations of CNTs grown using chemical vapor deposition on Si substrates: (a) entangled, randomly orientated CNTs;
(b) vertically aligned CNTs; (c) dense “dandelion-like” CNT structure grown using plasma-enhanced chemical vapor deposition on an
etched, catalyst-free Si substrate. Details on the growth of similar structures can be found in [40].
any application of these materials. Let us first briefly consider
the possible ways of performing such functionalization.
2.1. Functionalization of Carbon Nanotubes. Successful func-
tionalization should maintain the integrity of CNT’s
mechanical, electrical, and chemical properties as well as the
activity of the biological species being attached. In general,
there are two CNT functionalization methods: covalent
bonding and noncovalent wrapping [26–28].
Covalent bonding involves chemical attachment of the
desirable species to the CNT [26], often at the tube ends or
at defect sites [1, 29]. Oxidation processes are often used as a
preparation step to create chemically active sites for covalent
bonding [30]. These oxidation processes can be performed
through wet chemical or dry plasma routes [30], amongst
others. A variety of biological species have been covalently
bonded to CNTs [26, 31, 32]. However, this often alters
the intrinsic structure and properties of CNTs as well as
the properties of attached biomolecules [33]. An example
of a covalently functionalized CNT is shown in Figure 2(a),
which shows a scanning electron microscope (SEM) image
of multiwalled CNTs (MWCNTs) covalently functionalized
with ferritin [34].
Noncovalent bonding, or physical adsorption, on the
other hand, is the process of wrapping a species around
the CNT walls [27]. This method is preferable to covalent
bonding in many cases as it causes less structural damage
to the CNT and the wrapped species, and the chemical
environment required during fabrication is less harsh [28].
Over the years, the noncovalent wrapping of CNTs by
polysaccharides [33], DNA [35, 36], proteins, polypeptides
[37], and synthetic polymers has been widely reported.
The degree of CNT functionalization is commonly char-
acterized by atomic force microscopy, Raman spectroscopy,
SEM, transmission electron microscopy (TEM), ultraviolet-
visible light spectroscopy, Fourier-transform infrared spec-
troscopy, thermal gravimetric analysis, and gel electrophore-
sis [38, 39]. The bioactivity of the attached biomolecules
can be characterized by the immunochemical methods such
as enzyme-linked immunosorbent assay (ELISA) [38]. It
should be noted that whilst the bioactivity is strongly depen-
dent on the bonding between the biomolecule and the CNT,
the stoichiometry and the loading ratio are also important
factors that must be considered [32].
2.2. Carbon Nanotubes for Biosensing. The incorporation of
CNTs in biosensing devices has made a significant progress
in the last decade [39]. By definition, a biosensor is an
analytic device which consists of a receptor that interacts
with the targeted analyte to bemeasured and a transducer (or
detector) that transforms the signal from the interaction into
a form that can be easily measured. The one-dimensional
(1D) structure of CNTs allows signals to be transported in a
confined space, making them extremely sensitive to electrical
and chemical changes in their immediate environment
[8]. There are generally two configurations of CNT-based
biosensors: CNT field-eﬀect transistors (CNT-FETs) [41, 42]
and CNT electrochemical sensors [3, 43, 44]. Here, we
concentrate on these two types of biosensors and provide
details on the role of CNTs in these devices and the common
approaches employed to improve their sensitivity.
Carbon nanotube FET biosensors have a current carrying
channel connected to a source and a drain, which can be
regulated by a gate voltage [3]. A typical CNT-FET setup
is shown in Figure 2(b). The current carriers (electrons or
holes) running through the channel are highly sensitive
to changes in external electric fields and as such can be
used to detect electrical signals produced by biological
activity or biochemical interactions [45]. The conductive
channel in CNT-FET devices can be either an individual
semiconducting single-walled CNT (SWCNT) [46] or a
randomly distributed bundle of CNTs [8]. The former
was first introduced by Martel et al. [47] and has shown
superior performance compared to traditional metal-oxide-
semiconductor FETs (MOSFETs) [48]. Because of their
high sensitivity, CNT-FET biosensors are well suited for
the detection of very low analyte concentrations [8, 49].
For example, ultrasensitive detection of DNA at concen-
trations of 100 fM has been detected with SWCNT-FETs
[35, 50].
Semiconducting SWCNTs are often used in FET biosen-
sors as opposed to metallic SWCNTs since their conduc-
tivity can be gate-modulated by electrical changes in the
external environment [49]. Various purification processes
have been reported to separate metallic and semiconduct-
ing SWCNT mixtures, such as electrophoresis, centrifuga-
tion, chromatography, and solubilisation [55–57]. However,
purification of semiconducting SWNTs can add considerable
time and resources to the production process [56], and as
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Figure 2: (a) Transmission electron microscopy image of ferritin-functionalized MWNT (reproduced with permission from [34]); (b)
CNT-FET device for biosensing using antibody receptors (reproduced with permission from [22]); (c) Electrochemical sensor for glucose
consisting of an Au electrode bonded to a CNT-GOx which detects redox reactions between FAD and glucose (reproduced with permission
from [51]); (d) “basket-like” periodic MWNT lattices into which mice fibroblast is to be implanted (reproduced with permission from [52]);
(e) alginate-polylysinealginate microcapsule destruction by the photoacoustic eﬀect by folate acid—functionalized SWNTs inside the cells
(reproduced with permission from [53]); (f) loading and unloading of molecules inside CNTs for drug delivery; drugs are released when a
CNT is uncapped within the cytoplasm of the cell (reproduced with permission from [54]).
such should be taken into account when considering the
economic viability of CNT device fabrication.
Several approaches have been attempted to further
amplify the signals and improve the specificity and sensitivity
of CNT-FETs. One of these approaches is to bind specific
receptor species, which can undergo selective interactions
with the analyte, to the CNT channels. Many types of recep-
tors have been successfully bound to functionalized CNT-
FETs, such as aptamers [58], antibodies [59], sugars [60],
DNA [50], and proteins [49, 61]. Furthermore, decorating
the CNTs with conductive metal nanoparticles (typically Pt
and Au) can also amplify the detection signals [62]. Rajesh et
al. [63] demonstrated that the sensitivity of DNA detection
was 2.5 times greater after the addition of ZnS nanoparticles
into CNT-FETs.
Controlling the Schottky barrier eﬀect is another com-
mon way to amplify detection in CNT-FETs. Changes in the
conductivity of CNT-FETs are mostly due to gate coupling
eﬀects and the Schottky barrier eﬀect. The Schottky barrier
eﬀect arises from diﬀerences between the work functions
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of the CNT and the metal contacts [64] and is often hard
to predict, and is therefore detrimental to the sensor’s
performance [8]. Methods such as coating the metal contacts
with polymers have been used to minimize this eﬀect and
stabilize the response [64]. However, it should also be noted
that one can actually amplify the CNT-FET signals for
sensing applications by controlling the Schottky barrier eﬀect
[3, 65].
Real-time measurement is vital for the monitoring of
dynamic systems and is a promising approach for appli-
cations in fields such as bioterrorism, food safety, drug
testing, and on-the-spot medical diagnosis [65–67]. Carbon
nanotube FET biosensors have also been used to monitor
biological interactions in real time [8], including interactions
involving DNA [35], proteins [64], immunoglobulin [58],
morphine [45], and biological processes such as phagocytosis
[62]. Again, decoration by metal nanoparticles can be used
to improve the performance of CNT-FETs in real-time
measurements, as has been demonstrated in the cases of
glucose [35] and heroin [45].
On the other hand, CNT-based electrochemical biosen-
sors have been used to detect chemical redox interactions
[39, 68]. In this sensing mode the electrical properties and
small size of each CNT is preferred, as it allows them to act as
tiny electrodes with direct contact to biological systems. For
example, a SWCNT with a diameter of ∼1 nm is comparable
to the size of DNA and the active sites of proteins [69].
The 1D structure of CNTs also allows them to interact with
one species at a time, ideal for single-species biodetection
and biosensing [62, 70]. Carbon nanotube electrochemical
biosensors have been used to detect DNA [68], glucose [71,
72], proteins [49], enzymes [72], RNA [73–75], H2O2 [76],
andmany other biomolecules. Analogous to the case of CNT-
FET biosensors, functionalization of CNTs is important to
increase the specificity of the electrochemical biosensors.
Figure 2(c) shows an example of an electrochemical
biosensor, a gold electrode-CNT-glucose oxidase (GOx)
biosensor for detecting redox reactions between glucose (i.e.,
the analyte) and the redox active center of the GOx, flavin
adenine dinucleotide (FAD) [51]. The orientation of the
CNTs on the electrode has been found to be important for
sensing performance, with several studies showing that using
aligned CNTs increased the sensitivity of the device [18, 69].
Other biosensors rely on an array of CNTs perpendicular
to the electrode where the properties of the biosensor
sensitivity are dependent on the spatial distribution and
relative diameters of the CNTs in the array [50, 77]. Recently,
spun CNT fibers have also been attached to electrodes for
biosensing [78] and CNT fiber sensors have been reported to
detect glucose with greater sensitivity than traditional Pt-Ir
sensors [44].
Many diﬀerent methods have been used to improve the
sensitivity of CNT electrochemical biosensors. The most
common way has been to combine metal nanoparticles with
CNTs to increase the conductivity and redox activity of the
sensor [64, 71, 72, 78]. Other methods include gas treatment
[79], oxidation, and plasma etching [80, 81], which can
add extra functional groups (e.g., –COOH, –NH2) to the
CNTs. These functional groups act as active reaction sites
for analyte binding [82]. Lastly, optimizing the ratio of
semiconducting and metallic CNTs can also improve the
sensitivity [50] and even the response speed [78] of CNT
electrochemical sensors. For example, it has been shown
that biosensing devices using a mixture of metallic and
semiconducting CNTs performed better than those using
pure semiconducting CNTs alone [50].
Since many of these electrochemical biosensors are
used in real biological environments, it is often necessary
to prevent nonspecific binding of proteins, which can
interfere with the measurements. Polymer coatings such as
poly(ethylene glycol) (PEG) and poly(ethylene oxide) (PEO)
are often used to reduce nonspecific binding [8, 49, 83, 84].
However, care must be taken to choose the correct polymer
which does not distort the CNT and the biological receptor
[36].
It should be noted that there are many nanostructures
already used in biosensors, for example, Au nanoparticles
[85]. Au nanoparticles are gold clusters ranging from 1 to
100 nm in diameter [86] and are easily functionalized with
biomolecules such as DNA, enzymes, proteins, peptides,
oligonucleotides, glucose, and RNA [85, 86]. Biosensing
with Au nanoparticles is quite well established, especially
by enhanced surface plasmon resonance [86] and enhanced
Raman spectroscopy [86]. The toxicity of Au nanoparticles
is currently deemed minimal compared to CNTs [85, 87].
The main advantage of using CNTs in biosensors instead of
Au nanoparticles is that CNTs have many more parameters
that can be varied, which potentially allows a wider variety of
biosensors to be produced.
2.3. Carbon Nanotubes in Tissue Engineering. Tissue engi-
neering aims to repair, regenerate, and replace diseased or
damaged tissue. In tissue engineering, scaﬀolds are often
used to promote cell adhesion, growth, diﬀerentiation, and
proliferation in a three-dimensional (3D)matrix. These scaf-
folds also provide mechanical strength and add some degrees
of control over location and orientation of the attached cells.
Using CNTs as scaﬀolds has attracted great interest due to
their mechanical strength [13], chemical stability [14], and
biological inertness [52, 88]. Typically, carbon nanotubes are
grown into a 3D porous structure, or else coat an existing
3D porous structure, for example, collagen [89] and then
seeded with cells [90]. The cells are allowed to grow over
the scaﬀold until they become self-supporting [90]. Carbon
nanotube scaﬀolds can be fabricated into many diﬀerent
structures [91] with dimensions comparable to biological
cellular scaﬀolds [88, 92], which allows them to support a
wide range of biological species.
To promote cell growth and adhesion, CNTs are often
functionalized with, for example, carboxyl groups, poly-
mers, and sugars [13–15]. It has been shown that surface
charge, functional groups, and hydrophilicity are important
in determining cell adhesion and growth [93, 94]. For
example, in a study by Zhang et al., hydrophilic, neu-
trally charged amylose-CNT hybrid matrices supported cell
growth and proliferation as compared to chitosan-CNT,
sodium alginate-CNT, or chitosan-sodium-alginate-CNTs
[33].
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The periodicity, size, and structure of the CNT scaﬀolds
can also aﬀect the cellular interactions with the scaﬀold
[52, 95]. Vertically aligned MWCNTs can be fabricated into
3D scaﬀold matrices of periodic “basket-like” cavities, where
the cavity size and density depend on the dimensions of the
original array as shown in Figure 2(d) [52]. Mice fibroblast
cell lines L929 were successfully cultured on these periodic
matrices [52]. Patterns of CNTs can be fabricated by lithog-
raphy and used to direct the growth of cells such as human
mesenchymal stem cells (hMSCs) and neurons [96, 97]. In
particular, hMSCs have been found to grow and diﬀerentiate
well on 3D matrices of fibronectin (FN) functionalized
CNTs [98], but their growth was inhibited when seeded
on carboxylated CNT scaﬀolding [99]. The polarization of
neurons is also extremely sensitive to their environment;
hence CNTs could be used to direct neural connections and
interactions, potentially for in vivo applications [100].
Apart from using CNTs solely to construct scaﬀolds,
they can also be added to other scaﬀolding materials to
produce heterostructures. For example, porous polymer
composites can be produced by dispersing CNTs into PEG
or poly(propylene fumarate) (PPF) [101–103]. The addition
of CNTs allows the polymer composites to be electrically
conductive, which is useful for stimulating cell growth [104].
These composites have generally been used to promote
osteoblastic cell growth in vitro for bone regeneration
research [104–107] and also for neural regeneration [108,
109]
We also note that another carbon nanostructure that has
recently emerged as a potential scaﬀold material for tissue
engineering is nanodiamond. For example, a monolayer of
nanodiamonds has been shown to support neuronal cell
growth [110]. Nanodiamond crystals range from 2 to 10 nm
in diameter [111], are mechanically stable [110, 112], have a
large surface area [112], and are nontoxic [111]. However,
like the Au nanoparticles mentioned in Section 2.2, nan-
odiamonds have significantly fewer tunable characteristics
compared to CNTs, thus oﬀer fewer possibilities for tissue
scaﬀold designs.
2.4. Carbon Nanotubes in Drug Delivery. In delivering drugs,
the aim is to use a carrier molecule functionalized with
a receptor to carry a drug around the body until it
attaches to the problematic site, only then releasing the drug
[113]. Receptor-functionalized CNTs have been suggested as
targeted vehicles for drug delivery, where they are perceived
to have several advantages. Firstly, the nanometer size of
CNTs allows them to permeate into cellular membranes,
making them ideal for inserting drugs directly into cells
[16, 114, 115]. Secondly, each CNT can be functionalized to
detect and interact with a single cell, improving the delivery
eﬃciency and reducing the drug dosage [17, 116]. It has been
demonstrated that 5 million species can be bonded to an
80 nm long CNT [54]. The combination of size and ease of
functionalization allows CNT to deliver drugs to cells, such as
neurons and cardiomyocytes, which are diﬃcult to reach by
traditional drug-delivery methods [117]. Lastly, drugs can be
encapsulated into CNTs [54, 118–120], where release of the
drug in the desired cell compartment requires the chemical
disintegration of the CNT cap, as illustrated in Figure 2(f)
[22]. Successful examples include anticancer drugs and IR-
emitting molecules for direct heat treatment in vivo [121].
The CNT must have a drug-unloading mechanism for
the drug delivery to function eﬀectively [122]. Drug unload-
ing from CNT carriers can by triggered by environmental
changes, such as changes in temperature and pH [54]. For
example, intracellular pH is lower than extracellular pH; and
CNTs, which cross the membrane, can be activated to release
their drug load and influence intracellular processes [123].
This allows gene delivery straight into the nuclei of cells,
possible by “injection” of CNTs into cells [124]. Drugs may
also be released by optical stimulation using near-infrared
(700–1100 nm) wavelengths, which are not absorbed bymost
biological structures, in particular skin [125].
Apart from delivering specific drugs, CNTs can also be
functionalized for therapeutic applications. For example,
CNTs functionalized with folic acid can bind to cancer
cells, which can be killed by using infrared radiation to
induce vibration, that is, forming cellular “bombs” [53].
Similar research has been carried out in other studies
[125–128]. Figure 2(e) includes two images showing folate-
functionalized SWCNTs inside alginate-polylysine-alginate
microcapsules [53]. The first image shows the microcapsules
before IR irradiation and the second image shows the
obliterated microcapsules after irradiation [53]. This specific
targeting of cells reduces damage done to surrounding bio-
logical systems and is more eﬀective at destroying malignant
cells.
3. Nanotoxicity of Carbon Nanotubes
3.1. Background and Motivation. The diagnostic and ther-
apeutic applications of CNT-based materials mentioned
above will only be trialed clinically after detailed informa-
tion on their environmental and health and safety eﬀects
in host biological systems is obtained [129–131]. A few
preliminary tests have showed that CNTs are biologically
benign to certain cells, tissues, and organs under limited
conditions [132–134], while further studies have indicated
that CNTs are potential hazards that can cause both acute and
chronic adverse eﬀects to many living systems [4, 24, 135].
Nevertheless, at this stage, it appears that the biological
eﬀects of CNTs are sample specific and must be assessed on
a case-by-case basis. The nanotoxicity of CNTs, therefore,
requires continuing and extensive investigations and, indeed,
this will be required by regulatory bodies before CNTs can be
used in clinical environments as functional biomaterials and
biomedical devices.
Despite several years of research, definitive findings
regarding the extent of toxicological risks arising from using
nanotubes are far from complete. Continuing research is
required to determine, for example, how CNTs enter cells,
where CNTs are internalized, which the cytotoxic mecha-
nisms are relevant, and how the nanotoxicity is aﬀected by a
variety of physicochemical characteristics, such as diameter,
length, presence of impurities, surface functionalization,
and surface wettability. In this section, we give a brief
overview of the progress made to date on understanding
6 Journal of Nanomaterials
the nanotoxicity of CNTs, including the exposure, cellular
uptake, subcellular localization, and intracellular traﬃcking,
as well as mechanisms that may result in the mitigation and
inhibition of nanotoxicity.
3.2. The Production of and Exposure to CNTs. Despite their
relatively recent discovery [136], production of CNTs
had already reached 4000 tons by 2010 and could exceed
12000 tons by 2015 [137]. Such large-scale production has
inevitably led to exposure risks for both animals and human
beings. The most common ways for CNTs to enter the
host include inhalation, ingestion from food and water,
and absorption through skin wounds or scars [138]. In
laboratory-related exposure experiments, intravenous injec-
tion [4, 139, 140], intratracheal administration [141], and
abdominal implantation [142], are often employed to study
the nanotoxicity of CNTs in diﬀerent organs including the
lungs.
3.3. The Cellular Uptake of CNTs. The uptake of CNTs into
cells plays a critical role in determining their cytotoxicity
and genotoxicity. The outermost layer of the cell, the cellular
membrane, consists of a phospholipid bilayer [129], which
serves to segregate the subcellular compartments from the
external medium, and to regular the transport of foreign
materials, including CNTs, into cells [143].
Experimental results indicate that CNTs can be internal-
ized by a variety of cells. Although systematic knowledge is
still lacking, it is in general considered that there are two
possible pathways for CNTs to cross the cellular membrane
and enter cells [129]. One pathway is passive transport,
which includes diﬀusion, membrane fusion, and direct pore
transport [24, 144]. Individually dispersed CNTs in aqueous
solutions have been experimentally demonstrated to be able
to enter the cytoplasm of cells by directly crossing the
membrane [145, 146], despite recent modeling showing that
the energy cost of entering the cellular membrane via rupture
and diﬀusion was high compared to that of the energy of
thermal motion of CNTs [147].
A more common pathway for the cellular uptake of
CNTs is active transport via endocytosis, which includes
phagocytosis and pinocytosis [129, 143, 148]. Endocytosis
involves the enclosing of foreign objects in vesicles or
vacuoles pinched oﬀ from the cellular membrane. In general,
long CNTs (>1 μm in length) were taken up by phagocytosis,
which was mainly conducted by macrophages, monocytes,
and neutrophils [143]. Shorter CNTs of length from a few
to several hundred nanometers, on the other hand, were
mainly internalized by pinocytosis, such as macropinocytosis,
clathrin-mediated endocytosis, and caveolin-driven endocy-
tosis [129, 143]. Endocytosis is an energy-dependent process,
and the orientation of CNT entry can be controlled by
the interplay between the tip recognition through receptor
binding and the rotation driven by asymmetric elastic
strain at the nanotube-phospholipid bilayer interface, as
demonstrated recently by numerical modeling [149]. In
the most common case, a near-perpendicular orientation
resulted in a minimum energy barrier [147].
The exact cellular uptake pathway of CNTs is complex
and depends on many experimental parameters, such as the
size, length, hydrophobicity, surface chemistry, and the cell
culture medium. For example, the uptake of functionalized
SWCNTs in phagocytotic cells was found to occur via endo-
cytosis if they were longer than 400 nm and via diﬀusion-
controlled internalization if smaller than 400 nm [150].
Lee and Geckeler [129] have also shown that individual
MWCNTs entered cells through direct penetration in vitro,
whereas bundled MWCNTs entered via endocytosis.
Surface chemistry of SWCNTs also influences the cellular
uptake pathway [151]. It was demonstrated that when
SWCNTs were grafted with folate using PEGylation and
linked by phospholipid bilayer, they could enter HeLa cells
bound with the folate receptor (FR, a specific tumor marker)
but not those without FR. Similarly, when SWCNTs were
grafted with αvβ3, they could enter integrin- (a receptor
of αvβ3) positive U87-MG cells but not integrin-negative
cells [152]. If non-cell-targeting molecules were grafted, the
entry mode of CNTs will depend on the properties of the
conjugated molecules, for example, large molecules such
as bovine serum albumin (BSA) enter cells only through
endocytosis [152].
Additionally, the hydrophobic surface of CNTs can inter-
act with components in cell growth medium and aﬀect the
cellular uptake. Serum proteins in the cell growth medium
can bind to CNT walls through π-π interactions or elec-
trostatic attractions, forming a protein coating [129]. The
“screening eﬀect” of such protein coatings, known as the
“protein corona,” allows functionalized CNTs to experience
a similar cellular uptake pathway [129, 153].
Finally, the culture medium itself can aﬀect the cellular
uptake of CNTs. For example, single-walled CNTs grafted
with fluorescein isothiocyamate (FITC) were found to be
taken up by cells in a pH 5.8 medium, but the uptake was
inhibited in a slightly alkaline medium (pH 7.2) [154]. It
was suggested that under the alkaline condition, the anionic
form of FITC could dominate the neutral form and hamper
the cellular uptake of CNTs [154]. If properly exploited,
this property may facilitate the removal of the internalized
SWCNTs, though much more research is required.
3.4. Subcellular Localization and Intracellular Traﬃcking of
CNTs. Once taken into the cell, CNTs are often localized in
one of a number of diﬀerent subcellular compartments, for
example, cytoplasm, cytoskeleton, mitochondria, lysosomes,
endoplasmic reticulum, vesicles, and nuclei and can be
translocated between these compartments [143]. Because of
their small size and the weak contrast between these cellular
components and CNTs, it is often diﬃcult to characterize the
subcellular distribution of internalized CNTs. Over the years,
techniques, such as confocal and fluorescent microscopy,
TEM [4, 24], SEM with focused-ion beam (FIB) [155],
Raman spectroscopy [4, 140], and laser and photobleaching
[154], have been developed. For example, TEM is a very
eﬀective tool to see CNTs (and any other nanoparticles)
inside frozen cells. It was utilized by Porter et al. [24] to show
that SWCNTs were localized within lysosomes after 2 days,
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whereas after 4 days, bundles of SWCNTs were localized in
endosomes, translocated across the nuclear membrane, and
localized within the nucleus.
One of the major findings made in recent years in this
field is that the subcellular localization of CNTs depends on
howCNTs enter the cells.When functionalized CNTs directly
crossed the cell membrane, they were localized exclusively
inside mitochondria, whereas if being endocytosized, they
were located inside the lysosomes and phagososome [144,
148, 150]. Small CNTs that entered the cellular membrane
through diﬀusion were found mainly in the cell cytoplasm
[129, 150]. These preliminary findings have shed light on the
selective translocation and localization of SWCNTs to desired
subcellular components.
Figure 3 illustrates the main uptake pathways, the sub-
cellular localization, and the intracellular traﬃcking of
diﬀerently functionalized CNTs [129]. It is noted that the
internalized CNTs may be translocated between diﬀerent
subcellular components through carrier-mediated transport
[154]. For example, endocytosized MWCNTs accumulated
in the endosomes could be transported to the endoplasmic
reticulum, from which they translocated into the cytosol
[148]. Intracellular traﬃcking can also be eﬀectively con-
trolled by attaching a suitable functional tag on the CNTs. For
instance, FITC-SWCNTs were taken up in vacuoles through
carrier-mediated transport, but when functionalized with
an inhibitor of the carrier-mediated transport, they mostly
accumulated in the cytoplasm [154]. Further traﬃcking of
functionalized SWCNTs into nucleoplasm and the nucleus
were also observed [129].
3.5. Nanotoxicity Mechanisms in the Lungs. One of the
earliest concerns over the toxicity of CNTs arose from the
similarity of their structure (i.e., a fibrous shape and a high
aspect ratio) and biopersistence to asbestos, an infamous
carcinogenic material known to cause mesothelioma [141,
156, 157]. Asbestos has a fibrous structure of 20 to several
hundred nanometers in diameter. The toxicity of asbestos in
the lungs is thought to be mediated through the generation
of reactive oxygen species (ROS), which can induce the
activation of antioxidant defenses, causing the release of
proinflammatory and profibrotic cytokines from inflamma-
tory and epithelial cells, and activation of the apoptotic (cell
death) pathway [141, 158].
Carbon nanotubes in the lungs are often considered
less toxic than asbestos [141]. However, many experiments
have confirmed that they indeed show many asbestos-
like behaviors, although it is still unknown if they can
cause mesothelioma. The characteristics of cell deaths were
observed when lung cells were exposed to CNTs [24]. When
CNTs were inhaled, they were able to reach the subpleura and
cause subpleural fibrosis in mice [135]. Chronic exposure to
SWCNTs was also shown to cause the malignant transforma-
tion of human lung epithelial cells, which is evident for CNT-
induced carcinogenesis [156].
Besides the ability to generate ROS in lung cells [4,
159], other cytotoxic mechanisms of CNTs also include
blocking ion channels, regulating the intracellular calcium
level, binding to subcellular organelles and proteins to stop
their functions, and attacking the nucleus and damaging
DNA, which can induce apoptosis or necrosis cell deaths
and/ormutational cellular events [24, 160, 161]. These eﬀects
are in turn strongly influenced by the type, size, shape,
surface chemistry, and the route of administration of CNTs
[162].
The cytotoxic eﬀect of size and shape of CNTs is best
represented by their high aspect ratio, which results in
incomplete phagocytosis by the mononuclear cells because
the CNTs are too large [129]. This induced incomplete
or frustrated phagocytosis can result in macrophage acti-
vation and granulomatous inflammation. In fact, it has
been hypothesized that the failure of resident macrophages
to clear CNTs is the main reason for the activation of
proinflammatory pathways that induce lung fibrosis, lung
cancer, and malignant mesothelioma [149]. In addition, the
aggregation of CNTs by van der Waals’ interactions could
also aﬀect profibrogenic cellular responses and contribute to
the pulmonary toxicity of CNTs in vivo [141, 163].
In vivo studies using a mouse model also showed that
the pathological origin of CNTs was dependent on the
route of administration [164]. For the case of intratracheal
instillation, the agglomerates of CNTs with diﬀerent size
and morphology were observed in bronchi of mice, which
led to inflammation in 24 days. On the other hand, when
CNTs were inhaled, aggregation of CNTs was observed on the
lining wall of the bronchi but no inflammation was induced
[164].
Surface wettability is another factor that aﬀects the
cytotoxicity of CNTs. When macrophages are in contact
with hydrophilic CNTs, less inflammation was observed
compared to those in contact with hydrophobic CNTs or
titanium (a biocompatible metal) [165]. It was found that
less proinflammatory cytokines (e.g., tumor necrosis factor-
alpha, or TNF-alpha) and interleukin-6 (IL-6) were secreted
from macrophages containing hydrophilic CNTs. As a result,
hydrophobic CNTs are more toxic than their hydrophilic
counterparts.
A final remark on the pulmonary toxicity of CNTs is that
many nanoparticle impurities (e.g., Ni, Fe, and Co) carried
by CNTs are highly toxic. Removing these nanoparticle
impurities is necessary to show the intrinsic toxicity of CNTs
[129, 135, 166]. However, conventional purification routes
for removing these impurities may generate a high density
of functional groups or defects on CNTs, which in turn
influences the cytotoxicity. As demonstrated in a recent
study, purified CNTs have been shown to have the strongest
adverse eﬀects among pristine CNTs, carbon graphite, active
carbon, and carbon black.
3.6. Biodistribution and Nanotoxicity of CNTs in Other
Organs. Many in vivo studies have shown that CNTs deliv-
ered to a specific area in the body are not confined to that area
[139]. For example, intravenously injected CNTs were shown
to be taken up both by the liver and the spleen and then
excreted rapidly through the kidney [139, 140]. In contrast,
SWCNTs injected into the bloodstream of mice persisted
within liver and spleen macrophages (Kupﬀer cells) [4].
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Figure 3: The cellular uptake pathways, subcellular localization and intracellular traﬃcking of diﬀerently functionalized CNTs. (a) Super-
molecularly functionalized CNT via endocytosis, (b) covalently functionalized CNT bound with drugs via endocytosis, and (c) individual
or specifically functionalized CNT via direct penetration (reproduced with permission from [130]).
Singh et al. [167] also reported that intravenously injected
ammonia-functionalized SWCNTs were excreted mainly via
the renal route without uptake in the liver and spleen in mice
[167].
Because of the migration of CNTs in biological systems,
their toxicity to a variety of other organs should also be
tested. In many cases, macrophages, which form the first line
of defense against foreign materials, will interact with the
administrated CNTs [24]. This is why macrophages are one
of the mostly studied cells in in vitro investigations of CNT
toxicity. After CNTs have been ingested by macrophages,
they can enter into the blood and lymph circulation at a
later stage [24]. Carbon nanotubes can also be dispersed by
mucins (glycosylated proteins produced by epithelial tissues)
in certain cases and cleaned away in a physiological solution,
before they can interact with cells [168].
The long-term accumulation of SWCNTs in organs was
studied by Yang et al., who showed that no apoptosis was
induced in the main organs [4]. On the other hand, a low
percentage of early miscarriages and fetal malformations
was observed in female mice exposed to pristine SWCNTs
and ROS were detected in the placentas of malformed
fetuses [169]. Carbon nanotubes could also induce actin
(fibrous proteins that can form filaments and higher-order
network structures of the cytoskeleton and that perform
essential functions such as force generation, motility, and
division) bundling and reduced cell proliferation, which may
cause chronic changes to cellular functions [170]. Inhaled
MWCNTs were also shown to be able to suppress the
immune function of the spleen through the signals coming
from the lungs of the exposed mice [171, 172].
3.7. The Mitigation and Inhibition of CNT Nanotoxicity. In
attempting to fully utilize the excellent properties of CNTs
without being hampered by their adverse eﬀects, several
strategies have been proposed to mitigate or inhibit the
toxicity of CNTs. The most common method is through
surface functionalization [129, 143]. Noncovalently PEGy-
lated CNTs have been shown to be less toxic than oxidized
and pristine CNTs [4, 140, 169]. Repeated administrations of
carboxylated (CNT–COOH) and amine-CNTs (CNT–NH2)
in male mice caused only reversible testis damage with no
eﬀect on their fertility [173]. Other examples include cell-
adhesion peptides bound MWCNTs, which did not interfere
with neuronal functionality [174], and amine-functionalized
SWCNTs, which even protected the neurons [96].
Another way to reduce the cytotoxicity is through the
dispersion of CNTs in a biocompatible block copolymer
[141, 175, 176]. In vivo experiments showed that SWCNTs
functionalized with Pluronic polymers can be gradually
cleared from the body by alveolar macrophages through
mucociliary clearance, reducing risk of lung fibrosis [141].
Lastly, CNTs have been shown to be biodegradable to certain
enzymes, such as plant peroxidases, where the degraded
CNT fragments can then be eﬀectively phagocytosized by
surrounding cells [177, 178]. It has further been shown that
the biodegraded CNT fragments, when aspirated into the
lungs of mice, did not generate an inflammatory response
[178].
4. Graphene: Biomedical
Applications and Nanosafety
4.1. Introductory Remarks. Graphene, a 2D carbon nano-
material with a honeycomb-like structure, has been the
subject of a considerable interest after being the subject
of the 2010 Nobel Prize for Physics. Its unique properties,
including ballistic electron transport [179, 180] at room
temperature, tunable band-gap (for few-layer graphene),
high chemical and mechanical stability, low electrical noise,
high thermal conductivity, and biocompatibility, have led it
to be used in many advanced devices ranging from ultra-
capacitors to spintronic devices [181–186]. In line with the
purpose of this paper, however, we will concentrate on
the emerging biomedical-related applications of graphene
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and its derivatives (i.e., pristine graphene, graphene oxide,
metal nanoparticle decorated graphenes, vertical graphene
nanosheets, andmany other hybrid structures) in biosensors,
biocompatible scaﬀolds, tumor treatment, and drug delivery.
We will first present an overview of how and why graphene
is used in these cutting edge applications, followed by a brief
discussion of how to make graphene for these applications
using plasma-based fabrication and other methods.
4.2. Graphene Biosensing and Biomedical Applications. As
noted in Section 2, biosensors consist of two fundamental
parts—a biomolecular recognition element (receptor) and a
transducer. The former interacts with the analyte, whereas
the latter processes the “sensed” information and translates
it into a useable signal. Graphene is a particularly versatile
material as it can play a role in both of these compo-
nents, in plasmonic/optical- and electrical-based sensors. For
example, the aﬃnity of graphene for aromatic ring con-
taining biomolecules has been utilized in the biomolecular
recognition element in surface plasmon resonance (SPR)
sensors. Wu et al. [189] demonstrated that a graphene-Au
SPR biosensor, shown in Figure 4(d), was more sensitive
than a conventional Au-only SPR biosensor due to (1) the
greater adsorption eﬃciency of ring-based biomolecules on
graphene and (2) increased sensitivity to refractive index
(RI) changes (a 25% increase in sensitivity to RI change
for 10 graphene layers compared to the Au only case). This
aﬃnity can also be used as the basis for graphene surface-
enhanced Raman scattering (SERS) sensors [190]. Ling et
al. [187] reported that using a graphene substrate resulted
in a SERS enhancement (see Figures 4(a)–4(c)) of common
SERS probes including Rhodamine 6G and crystal violet.
This enhancement is chemical, rather than electromagnetic,
in nature. Specifically, it is due to the π-π stacking that occurs
when the ring-containing molecule aligns itself parallel to
the graphene basal plane—this stacking means that charge
transfer between graphene and the biomolecule occurs easily,
resulting in a chemical SERS enhancements of around 2–
17 times [187]. This chemical enhancement, however, is
markedly less than the electromagnetic SERS enhancement
achieved when Ag or Au nanostructures are used as SERS
substrates, despite graphene’s higher bioaﬃnity.
Vertical graphenes (such as those in Figures 5(a) and
5(b)) can, however, be used in combination with metal
nanoparticles to make 3D metal-graphene nanohybrid SERS
platforms. Rider et al. [188] presented a novel SERS substrate
consisting of vertical graphenes decorated with Au nanopar-
ticles (see Figures 5(d–g)). Using vertical, rather than
horizontal, graphenes provides a markedly higher eﬀective
“bookshelf” like area to which Au nanoparticles can attach—
a conservative estimate puts the bookshelf nanoparticle
density as 224% greater than that for the “flat sensor area”
[188]. This means that there is a much greater area to which
analyte species can attach, compared to typical horizontal
sensor architectures. Gold-decorated graphene composites
have also been used in electrodes for electrochemical sensors,
due to their high electrocatalytic activity and electrochem-
ical stability [195]. In addition, making use of the high
fluorescence quenching eﬃciency of graphene, Chang et
al. [196] constructed a graphene fluorescence resonance
energy transfer (FRET) aptasensor, with a reported thrombin
detection limit two orders of magnitude lower than CNT-
based FRET sensors.
Electrical sensors that have incorporated graphene
include electrochemical-impedance based sensors [197],
electrochemical sensors (in which graphene-related materi-
als form the electrode) [198], and FET sensors [194, 199,
200]. Wan et al. [197] constructed immunosensors based on
electrochemical impedance with reduced graphene sheets as
electron conductors [197]. Ohno et al. [194, 201] showed
that graphene FETs (such as those shown in Figure 5(f))
could be used for label-free biosensing—specifically, they
demonstrated electrical detection (via a change in the
drain current) of solution pH, protein adsorption and
specific biomolecules (such as IgE). Zhang et al. noted that
the hydrophobic interaction between certain proteins and
chemically reduced graphene oxide is promising for protein
immobilization and as a result could be used in a biosensor
[202].
Aside from sensors, the biocompatibility and chemical
inertness (the basal plane, not the edges, which are quite
reactive) of graphene surfaces have led to their use as
biocompatible scaﬀolds for the growth of human osteoblasts
[203] as well as components in drug delivery and tumor
treatment routes [193, 204–206]. Use of graphene oxide as a
drug delivery vehicle for anticancer drug doxorubicin [207]
is shown in Figure 5(e). Due to the strong optical absorbance
of graphene nanosheets in the near infrared, they have been
used as a crucial component in photothermal treatment
[192, 208, 209] with reported eﬃcient tumor ablation; this
can be clearly seen in Figure 5(c), where the best tumor
ablation was observed in mice treated with PEG-graphene
nanosheets, indicated by the star [192]. The passage of single
molecules through nanochannels or nanopores is important
formany biological diagnosis processes [210] including DNA
sequencing [211, 212]—nanopores in graphene have recently
been used for single DNA molecule translocation [213].
Diagnostics and therapies do not exist in a vacuum, they
are informed by each other—leading to mutual benefits—
this is reflected in the emerging term “theranostics,” focusing
on individualized medical treatments [214]. This is an area
in which graphene-related materials, as already indicated by
Yang et al. [192, 215], can play a very important role as
their properties lend them both to sensing and intervention/
treatment methods.
4.3. Nanosafety and Nanotoxicity of Graphene. As mentioned
in Section 3, for any biological-related application, particu-
larly in vivo applications, great care must be taken to ensure
that the toxicity of the nanomaterial is well characterized
and understood. Whilst this has been extensively done for
carbon nanotubes, markedly fewer studies [158, 216–222]
are available for graphenes (e.g., an ISI Web of Knowledge
topic search on 03/01/2012 gave 59 hits for “graphene”
and “toxicity” compared to 1668 hits for “nanotube” and
“toxicity”). There is even less consensus as to the sagacity of
using this next-generationmaterial as an integral component
in in vivo applications. Zhang et al. [158] compared the
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cytotoxicity level of graphene to that of carbon nanotubes in
the case of neuronal PC12 cells. They found that toxicity was
shape and composition dependent, with graphene overall
having a lower toxicity than CNTs; however the toxicity of
graphene was curiously found to be inverse to concentration
[223], with graphene exhibiting a higher toxicity than CNTs
at low concentrations [223]. Studies on the uptake of
PEG-coated graphene nanosheets in mice and subsequent
photothermal treatment of cancerous tumors did not show
any adverse toxic eﬀects [192, 215]. In other studies, however,
sharp graphene nanosheet edges [216] have been shown to
cause considerable damage to the cell membrane of bacteria,
although this antibacterial property has the potential to
be useful. Moreover, hydrophilic carboxyl-functionalized
graphenes have been shown to be able to be internalized in
cells without any toxic eﬀects, in contrast to hydrophobic
pristine graphene [224]. The biocompatibility of graphene
oxide has also been studied, with toxicity shown to be dose-
dependent in both humans and animals [225], with little to
no eﬀect for low and medium doses in mice [225]. Graphene
oxide nanosheets were demonstrated to be biocompatible
with yeast cells [226]. With the wide range of morphologies,
coatings, and hybrid structures available for graphenes, more
detailed and longer-term studies are required before serious
in vivo biomedical graphene applications are implemented.
4.4. Fabrication of Vertically Aligned Graphene Structures.
Many diﬀerent fabrication methods have been used to
make graphene-related materials, from the first successful
isolation via micromechanical cleavage [227], to chemical
reduction of graphene oxide [228, 229], chemical vapour
deposition (CVD) [230, 231], thermal decomposition of
SiC [232], plasma nanofabrication techniques including
plasma-enhanced CVD [233, 234] and arc discharges [235],
as well as unzipping of CNTs via a variety of methods
(e.g., chemical treatment, plasma etching) [236, 237]. For a
detailed description of the relative merits of these fabrication
methods, we refer the interested reader to two comprehensive
reviews [238, 239]. As noted in Section 4.2, vertically aligned
graphene structures have beneficial properties for sensing
and other biomedical devices. However, so far there have
been limited successes in fabricating these structures. In par-
ticular, plasma-based self-organization [240] is a promising
way to grow catalyst-free, high-quality vertical graphenes
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[191, 241]. Papers by Seo and Kumar et al. [20, 191, 241]
have shown that it is possible to grow graphene nanosheets
with a variety of morphologies (e.g., unidirectional, or see
Figure 5(a) for turnstile and Figure 5(b) for maze-like) with
diﬀerent optoelectronic properties by modifying the plasma
parameters such as gas composition and the degree of
ionization. Plasma-based fabrication routes reduce human
exposure to any hazardous byproducts since the growth is
conducted under vacuum. Moreover, the nanostructures are
typically surface-bound, which means they are less likely to
be ingested or inhaled, as discussed for CNTs in Section 3
[131].
5. Summary and Outlook
In this paper, we have discussed the promising future of
incorporating CNTs into the field of biomedicine, specifically
their current roles in biosensing, drug delivery, and tissue
engineering. The benefits of CNTs were presented, together
with potential nanotoxicity and harmful eﬀects of CNTs, on
biological systems. Also discussed were the potential uses
for graphene for similar biomedical applications as well as
the problems associated with graphene’s toxicity and safety.
There are many challenges ahead that must be addressed
before CNTs and graphene can be successfully integrated
into biomedical devices and technology. The main advances
required, in our opinions, include the following.
(i) Advanced techniques and facile methods are needed
to increase the sensitivity of CNT biosensors towards
single-molecule detection.
(ii) More eﬃcient loading and unloading methods for
drug delivery would refine overall performance of
CNTs as carriers.
(iii) Further research is required into various CNT hybrid
scaﬀolds to promote cell adhesion, growth, diﬀeren-
tiation, and proliferation.
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(iv) More specialized coatings and CNT-functionaliza-
tion to minimize nonspecific bonding are needed.
(v) Protocols and further experiments should be con-
ducted to determine the exact nature of the nanotox-
icity of CNT-based and graphene-based materials.
(vi) Innovative ideas and further experiments are needed
to further develop the use of graphene in advanced
biomedical applications.
(vii) Innovative solutions are required to reduce fabrica-
tion and running costs of CNT and graphene bio-
medical devices to make them economically viable.
The long-term goals associated with incorporating CNTs
and graphene into biomedical technology suggest that fur-
ther research is required before these carbon nanostructured
devices reach suﬃcient performance standards.
Authors’ Contribution
C. Fisher, A. Rider, and Z. Han contributed equally to this
work.
Acknowledgments
The authors would like to thank Q. Cheng, S. Yick, T. van
der Laan, D. H. Seo, and W. Yan for insightful discussion. C.
Fisher acknowledges the CSIROOCEHonors Scholarship for
Electroactive Biomaterials, A. Rider and Z. Han acknowledge
the CSIRO OCE Postdoctoral Fellowship and support from
the CSIRO Sensors and Sensor Network TCP. This work is
supported by the Australian Research Council (ARC) and
CSIRO’s OCE Science Leadership Program.
References
[1] M. S. Dresselhaus, G. Dresselhaus, J. C. Charlier, and E.
Herna´ndez, “Electronic, thermal and mechanical properties
of carbon nanotubes,” Philosophical Transactions of the Royal
Society A, vol. 362, no. 1823, pp. 2065–2098, 2004.
[2] S. Chakrabarti, H. Kume, L. Pan, T. Nagasaka, and
Y. Nakayama, “Number of walls controlled synthesis of
millimeter-long vertically aligned brushlike carbon nan-
otubes,” Journal of Physical Chemistry C, vol. 111, no. 5, pp.
1929–1934, 2007.
[3] S. N. Kim, J. F. Rusling, and F. Papadimitrakopoulos, “Car-
bon nanotubes for electronic and electrochemical detection
of biomolecules,” Advanced Materials, vol. 19, no. 20, pp.
3214–3228, 2007.
[4] S. T. Yang, X. Wang, G. Jia et al., “Long-term accumulation
and low toxicity of single-walled carbon nanotubes in
intravenously exposed mice,” Toxicology Letters, vol. 181, no.
3, pp. 182–189, 2008.
[5] C. Fisher, Z. J. Han, I. Levchenko, and K. Ostrikov, “Control
of dense carbon nanotube arrays via hierarchical multilayer
catalyst,” Applied Physics Letters, vol. 99, no. 14, Article ID
143104, 2011.
[6] Z. J. Han, I. Levchenko, S. Yick, and K. Ostrikov, “3-
Orders-of-magnitude density control of single-walled carbon
nanotube networks by maximizing catalyst activation and
dosing carbon supply,” Nanoscale, vol. 3, no. 11, pp. 4848–
4853, 2011.
[7] Z. J. Han, S. Yick, I. Levchenko et al., “Controlled synthesis
of a large fraction of metallic single-walled carbon nanotube
and semiconducting carbon nanowire networks,” Nanoscale,
vol. 3, no. 8, pp. 3214–3220, 2011.
[8] G. Gruner, “Carbon nanotube transistors for biosensing
applications,” Analytical and Bioanalytical Chemistry, vol.
384, no. 2, pp. 322–335, 2006.
[9] M. O’Connor, N. K. Sang, A. J. Killard et al., “Mediated
amperometric immunosensing using single walled carbon
nanotube forests,” Analyst, vol. 129, no. 12, pp. 1176–1180,
2004.
[10] M. Pumera, “The electrochemistry of carbon nanotubes:
fundamentals and applications,” Chemistry, vol. 15, no. 20,
pp. 4970–4978, 2009.
[11] V. Vamvakaki, M. Fouskaki, and N. Chaniotakis, “Electro-
chemical biosensing systems based on carbon nanotubes and
carbon nanofibers,” Analytical Letters, vol. 40, no. 12, pp.
2271–2287, 2007.
[12] A. Merkoc¸i, “Carbon nanotubes in analytical sciences,”
Microchimica Acta, vol. 152, no. 3-4, pp. 157–174, 2006.
[13] B. S. Harrison and A. Atala, “Carbon nanotube applications
for tissue engineering,” Biomaterials, vol. 28, no. 2, pp. 344–
353, 2007.
[14] L. Zhang and T. J. Webster, “Nanotechnology and nano-
materials: promises for improved tissue regeneration,” Nano
Today, vol. 4, no. 1, pp. 66–80, 2009.
[15] T. Dvir, B. P. Timko, D. S. Kohane, and R. Langer, “Nanotech-
nological strategies for engineering complex tissues,” Nature
Nanotechnology, vol. 6, no. 1, pp. 13–22, 2011.
[16] O. C. Farokhzad and R. Langer, “Impact of nanotechnology
on drug delivery,” ACS Nano, vol. 3, no. 1, pp. 16–20, 2009.
[17] A. Bianco, K. Kostarelos, and M. Prato, “Applications of
carbon nanotubes in drug delivery,” Current Opinion in
Chemical Biology, vol. 9, no. 6, pp. 674–679, 2005.
[18] Y. Lin, F. Lu, Y. Tu, and Z. Ren, “Glucose biosensors based
on carbon nanotube nanoelectrode ensembles,”Nano Letters,
vol. 4, no. 2, pp. 191–195, 2004.
[19] L. Lacerda, A. Bianco, M. Prato, and K. Kostarelos, “Carbon
nanotubes as nanomedicines: from toxicology to pharmacol-
ogy,” Advanced Drug Delivery Reviews, vol. 58, no. 14, pp.
1460–1470, 2006.
[20] S. Kumar and K. Ostrikov, “Unidirectional arrays of vertically
standing graphenes in reactive plasmas,” Nanoscale, vol. 3,
no. 10, pp. 4296–4300, 2011.
[21] M. Bottini, N. Rosato, andN. Bottini, “PEG-modified carbon
nanotubes in biomedicine: current status and challenges
ahead,” Biomacromolecules, vol. 12, no. 10, pp. 3381–3393,
2011.
[22] D. W. H. Fam, A. Palaniappan, A. I. Y. Tok, B. Liedberg,
and S. M. Moochhala, “A review on technological aspects
influencing commercialization of carbon nanotube sensors,”
Sensors and Actuators B, vol. 157, no. 1, pp. 1–7, 2011.
[23] C. W. Lam, J. T. James, R. McCluskey, S. Arepalli, and
R. L. Hunter, “A review of carbon nanotube toxicity and
assessment of potential occupational and environmental
health risks,” Critical Reviews in Toxicology, vol. 36, no. 3, pp.
189–217, 2006.
[24] A. E. Porter, M. Gass, K. Muller, J. N. Skepper, P. A. Midgley,
and M. Welland, “Direct imaging of single-walled carbon
nanotubes in cells,”Nature Nanotechnology, vol. 2, no. 11, pp.
713–717, 2007.
Journal of Nanomaterials 13
[25] C. P. Firme and P. R. Bandaru, “Toxicity issues in the
application of carbon nanotubes to biological systems,”
Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 6,
no. 2, pp. 245–256, 2010.
[26] X. Peng and S. S. Wong, “Functional covalent chemistry of
carbon nanotube surfaces,” Advanced Materials, vol. 21, no.
6, pp. 625–642, 2009.
[27] M. Shim, N. W. S. Kam, R. J. Chen, Y. Li, and H. Dai,
“Functionalization of carbon nanotubes for biocompatibility
and biomolecular recognition,”Nano Letters, vol. 2, no. 4, pp.
285–288, 2002.
[28] C. Y. Hu, Y. J. Xu, S. W. Duo, R. F. Zhang, and M. S. Li,
“Non-covalent functionalization of carbon nanotubes with
surfactants and polymers,” Journal of the Chinese Chemical
Society, vol. 56, no. 2, pp. 234–239, 2009.
[29] J. N. Coleman, U. Khan, W. J. Blau, and Y. K. Gun’ko, “Small
but strong: a review of the mechanical properties of carbon
nanotube-polymer composites,” Carbon, vol. 44, no. 9, pp.
1624–1652, 2006.
[30] N. Karousis, N. Tagmatarchis, andD. Tasis, “Current progress
on the chemical modification of carbon nanotubes,” Chemi-
cal Reviews, vol. 110, no. 9, pp. 5366–5397, 2010.
[31] W. Huang, S. Taylor, K. Fu et al., “Attaching proteins to
carbon nanotubes via diimide-activated amidation,” Nano
Letters, vol. 2, no. 4, pp. 311–314, 2002.
[32] S. S. Karajanagi, A. A. Vertegel, R. S. Kane, and J. S. Dordick,
“Structure and function of enzymes adsorbed onto single-
walled carbon nanotubes,” Langmuir, vol. 20, no. 26, pp.
11594–11599, 2004.
[33] X. Zhang, L. Meng, and Q. Lu, “Cell behaviors on polysac-
charide-wrapped single-wall carbon nanotubes: a quantita-
tive study of the surface properties of biomimetic nanofi-
brous scaﬀolds,” ACS Nano, vol. 3, no. 10, pp. 3200–3206,
2009.
[34] K. Jiang, L. S. Schadler, R. W. Siegel, X. Zhang, H. Zhang, and
M. Terrones, “Protein immobilization on carbon nanotubes
via a two-step process of diimide-activated amidation,”
Journal of Materials Chemistry, vol. 14, no. 1, pp. 37–39, 2004.
[35] J. W. Ko, J. M. Woo, A. Jinhong et al., “Multi-order dynamic
range DNA sensor using a gold decorated SWCNT random
network,” ACS Nano, vol. 5, no. 6, pp. 4365–4372, 2011.
[36] Y. Weizmann, D. M. Chenoweth, and T. M. Swager, “Address-
able terminally linked DNA-CNT nanowires,” Journal of the
American Chemical Society, vol. 132, no. 40, pp. 14009–
14011, 2010.
[37] K. A. Williams, P. T. M. Veenhuizen, B. G. De la Torre, R.
Eritja, and C. Dekker, “Nanotechnology: carbon nanotubes
with DNA recognition,” Nature, vol. 420, no. 6917, p. 761,
2002.
[38] W. Huang, S. Taylor, K. Fu et al., “Attaching proteins to
carbon nanotubes via diimide-activated amidation,” Nano
Letters, vol. 2, no. 4, pp. 311–314, 2002.
[39] W. Yang, P. Thordarson, J. J. Gooding, S. P. Ringer, and
F. Braet, “Carbon nanotubes for biological and biomedical
applications,” Nanotechnology, vol. 18, no. 41, Article ID
412001, 2007.
[40] S. Kumar, I. Levchenko, K. Ostrikov, and J. A. McLaughlin,
“Plasma-enabled, catalyst-free growth of carbon nanotubes
on mechanically-written Si features with arbitrary shape,”
Carbon, vol. 50, no. 1, pp. 325–329, 2012.
[41] X. Guo, L. Huang, S. O’Brien, P. Kim, and C. Nuckolls,
“Directing and sensing changes in molecular conformation
on individual carbon nanotube field eﬀect transistors,”
Journal of the American Chemical Society, vol. 127, no. 43, pp.
15045–15047, 2005.
[42] Z. Kuang, S. N. Kim, W. J. Crookes-Goodson, B. L. Farmer,
and R. R. Naik, “Biomimetic chemosensor: designing peptide
recognition elements for surface functionalization of carbon
nanotube field eﬀect transistors,” ACS Nano, vol. 4, no. 1, pp.
452–458, 2010.
[43] X. Yu, D. Chattopadhyay, I. Galeska, F. Papadimitrakopoulos,
and J. F. Rusling, “Peroxidase activity of enzymes bound to
the ends of single-wall carbon nanotube forest electrodes,”
Electrochemistry Communications, vol. 5, no. 5, pp. 408–411,
2003.
[44] Z. Zhu,W. Song, K. Burugapalli, F. Moussy, Y. L. Li, and X. H.
Zhong, “Nano-yarn carbon nanotube fiber based enzymatic
glucose biosensor,”Nanotechnology, vol. 21, no. 16, Article ID
165501, 2010.
[45] S. G. Mhaisalkar, J. N. Tey, S. Gandhi et al., “Direct detection
of heroin metabolites using a competitive immunoassay
based on a carbon-nanotube liquid-gated field-eﬀect transis-
tor,” Small, vol. 6, no. 9, pp. 993–998, 2010.
[46] D. W. H. Fam and A. I. Y. Tok, “Mono-distributed single-
walled carbon nanotube channel in field eﬀect transistors
(FETs) using electrostatic atomization deposition,” Journal
of Colloid and Interface Science, vol. 338, no. 1, pp. 266–269,
2009.
[47] R. Martel, T. Schmidt, H. R. Shea, T. Hertel, and P.
Avouris, “Single- andmulti-wall carbon nanotube field-eﬀect
transistors,” Applied Physics Letters, vol. 73, no. 17, pp. 2447–
2449, 1998.
[48] S. Roy and Z. Gao, “Nanostructure-based electrical biosen-
sors,” Nano Today, vol. 4, no. 4, pp. 318–334, 2009.
[49] R. J. Chen, S. Bangsaruntip, K. A. Drouvalakis et al., “Non-
covalent functionalization of carbon nanotubes for highly
specific electronic biosensors,” Proceedings of the National
Academy of Sciences of the United States of America, vol. 100,
no. 9, pp. 4984–4989, 2003.
[50] D. Fu, H. Okimoto, C. W. Lee et al., “Ultrasensitive detection
of DNA molecules with high on/oﬀ single-walled carbon
nanotube network,” Advanced Materials, vol. 22, no. 43, pp.
4867–4871, 2010.
[51] A. Merkoc¸i, M. Pumera, X. Llopis, B. Pe´rez, M. Del Valle, and
S. Alegret, “New materials for electrochemical sensing VI:
carbon nanotubes,” TrAC—Trends in Analytical Chemistry,
vol. 24, no. 9, pp. 826–838, 2005.
[52] M. A. Correa-Duarte, N. Wagner, J. Rojas-Chapana, C.
Morsczeck, M. Thie, and M. Giersig, “Fabrication and bio-
compatibility of carbon nanotube-based 3D networks as
scaﬀolds for cell seeding and growth,” Nano Letters, vol. 4,
no. 11, pp. 2233–2236, 2004.
[53] B. Kang, D. Yu, Y. Dai, S. Chang, D. Chen, and Y. Ding,
“Cancer-cell targeting and photoacoustic therapy using car-
bon nanotubes as “bomb” agents,” Small, vol. 5, no. 11, pp.
1292–1301, 2009.
[54] T. A. Hilder and J. M. Hill, “Encapsulation of the anticancer
drug cisplatin into nanotubes,” in International Conference on
Nanoscience and Nanotechnology (ICONN ’08), pp. 109–112,
February 2008.
[55] N. Komatsu and F. Wang, “A comprehensive review on
separation methods and techniques for single-walled carbon
nanotubes,” Materials, vol. 3, no. 7, pp. 3818–3844, 2010.
[56] R. Krupke, F. Hennrich, H. V. Lo¨hneysen, andM. M. Kappes,
“Separation of metallic from semiconducting single-walled
carbon nanotubes,” Science, vol. 301, no. 5631, pp. 344–347,
2003.
14 Journal of Nanomaterials
[57] P. Łukaszczuk, E. Borowiak-Palen´, M. H. Ru¨mmeli, and R.
J. Kalen´czuk, “Gel-based separation of single-walled carbon
nanotubes for metallic and semiconducting fractions,” Mate-
rials Research Bulletin, vol. 46, no. 10, pp. 1535–1539, 2011.
[58] K. Maehashi, T. Katsura, K. Kerman, Y. Takamura, K. Mat-
sumoto, and E. Tamiya, “Label-free protein biosensor based
on aptamer-modified carbon nanotube field-eﬀect transis-
tors,” Analytical Chemistry, vol. 79, no. 2, pp. 782–787, 2007.
[59] K. Bradley, M. Briman, A. Star, and G. Gruner, “Charge
transfer from adsorbed proteins,” Nano Letters, vol. 4, no. 2,
pp. 253–256, 2004.
[60] L. N. Cella, W. Chen, N. V. Myung, and A. Mulchandani,
“Single-walled carbon nanotube-based chemiresistive aﬃn-
ity biosensors for small molecules: ultrasensitive glucose
detection,” Journal of the American Chemical Society, vol. 132,
no. 14, pp. 5024–5026, 2010.
[61] R. J. Chen, H. C. Choi, S. Bangsaruntip et al., “An investi-
gation of the mechanisms of electronic sensing of protein
adsorption on carbon nanotube devices,” Journal of the
American Chemical Society, vol. 126, no. 5, pp. 1563–1568,
2004.
[62] I. Heller, W. T. T. Small, S. G. Lemay, and C. Dekker, “Probing
macrophage activity with carbon-nanotube sensors,” Small,
vol. 5, no. 22, pp. 2528–2532, 2009.
[63] Rajesh, B. K. Das, S. Srinives, and A. Mulchandani, “ZnS
nanocrystals decorated single-walled carbon nanotube based
chemiresistive label-free DNA sensor,”Applied Physics Letters,
vol. 98, no. 1, Article ID 013701, 2011.
[64] I. Heller, A. M. Janssens, J. Ma¨nnik, E. D. Minot, S. G. Lemay,
and C. Dekker, “Identifying the mechanism of biosensing
with carbon nanotube transistors,” Nano Letters, vol. 8, no.
2, pp. 591–595, 2008.
[65] F. N. Ishikawa, B. Stauﬀer, D. A. Caron, and C. Zhou, “Rapid
and label-free cell detection by metal-cluster-decorated car-
bon nanotube biosensors,” Biosensors and Bioelectronics, vol.
24, no. 10, pp. 2967–2972, 2009.
[66] T. H. Kim, S. H. Lee, J. Lee et al., “Single-carbon-atomic-
resolution detection of odorant molecules using a human
olfactory receptor-based bioelectronic nose,”AdvancedMate-
rials, vol. 21, no. 1, pp. 91–94, 2009.
[67] G. Peng, E. Track, and H. Haick, “Detecting simulated
patterns of lung cancer biomarkers by random network of
single-walled carbon nanotubes coated with nonpolymeric
organic materials,” Nano Letters, vol. 8, no. 11, pp. 3631–
3635, 2008.
[68] H. Wang, R. Yang, L. Yang, and W. Tan, “Nucleic acid con-
jugated nanomaterials for enhanced molecular recognition,”
ACS Nano, vol. 3, no. 9, pp. 2451–2460, 2009.
[69] J. J. Gooding, R. Wibowo, J. Liu et al., “Protein electrochem-
istry using aligned carbon nanotube arrays,” Journal of the
American Chemical Society, vol. 125, no. 30, pp. 9006–9007,
2003.
[70] H. Jin, D. A. Heller, M. Kalbacova et al., “Detection of single-
molecule H2O2 signalling from epidermal growth factor
receptor using fluorescent single-walled carbon nanotubes,”
Nature Nanotechnology, vol. 5, no. 4, pp. 302–309, 2010.
[71] X. B. Yan, X. J. Chen, B. K. Tay, and K. A. Khor, “Transparent
and flexible glucose biosensor via layer-by-layer assembly
of multi-wall carbon nanotubes and glucose oxidase,” Elec-
trochemistry Communications, vol. 9, no. 6, pp. 1269–1275,
2007.
[72] R. Cui, H. Huang, Z. Yin, D. Gao, and J. J. Zhu, “Horseradish
peroxidase-functionalized gold nanoparticle label for ampli-
fied immunoanalysis based on gold nanoparticles/carbon
nanotubes hybrids modified biosensor,” Biosensors and Bio-
electronics, vol. 23, no. 11, pp. 1666–1673, 2008.
[73] T. Dastagir, E. S. Forzani, R. Zhang et al., “Electrical detection
of hepatitis C virus RNA on single wall carbon nanotube-
field eﬀect transistors,” Analyst, vol. 132, no. 8, pp. 738–740,
2007.
[74] X. Tang, S. Bansaruntip, N. Nakayama, E. Yenilmez, Y. I.
Chang, and Q. Wang, “Carbon nanotube DNA sensor and
sensing mechanism,” Nano Letters, vol. 6, no. 8, pp. 1632–
1636, 2006.
[75] H. M. So, D. W. Park, E. K. Jeon et al., “Detection and
titer estimation of Escherichia coli using aptamer-functional-
ized single-walled carbon-nanotube field-eﬀect transistors,”
Small, vol. 4, no. 2, pp. 197–201, 2008.
[76] E. Nossol and A. J. G. Zarbin, “A simple and innovative route
to prepare a novel carbon nanotube/prussian blue electrode
and its utilization as a highly sensitive H2O2 amperometric
sensor,” Advanced Functional Materials, vol. 19, no. 24, pp.
3980–3986, 2009.
[77] F. N. Ishikawa, M. Curreli, C. A. Olson et al., “Importance
of controlling nanotube density for highly sensitive and
reliable biosensors functional in physiological conditions,”
ACS Nano, vol. 4, no. 11, pp. 6914–6922, 2010.
[78] J. Wang, “Electrochemical glucose biosensors,” Chemical
Reviews, vol. 108, no. 2, pp. 814–825, 2008.
[79] X. Xu, S. Jiang, Z. Hu, and S. Liu, “Nitrogen-doped carbon
nanotubes: high electrocatalytic activity toward the oxidation
of hydrogen peroxide and its application for biosensing,” ACS
Nano, vol. 4, no. 7, pp. 4292–4298, 2010.
[80] C. Ferna´ndez-Sa´nchez, E. Pellicer, J. Orozco, C. Jime´nez-
Jorquera, L. M. Lechuga, and E. Mendoza, “Plasma-activated
multi-walled carbon nanotube-polystyrene composite sub-
strates for biosensing,” Nanotechnology, vol. 20, no. 33,
Article ID 335501, 2009.
[81] Z. Wu, Y. Xu, X. Zhang, G. Shen, and R. Yu, “Microwave
plasma treated carbon nanotubes and their electrochemical
biosensing application,” Talanta, vol. 72, no. 4, pp. 1336–
1341, 2007.
[82] K. Jiang, A. Eitan, L. S. Schadler et al., “Selective attachment
of gold nanoparticles to nitrogen-doped carbon nanotubes,”
Nano Letters, vol. 3, no. 3, pp. 275–277, 2003.
[83] S. Srivastava and J. LaBaer, “Nanotubes light up protein
arrays,” Nature Biotechnology, vol. 26, no. 11, pp. 1244–1246,
2008.
[84] A. Star, J. C. P. Gabriel, K. Bradley, and G. Gru¨ner, “Electronic
detection of specific protein binding using nanotube FET
devices,” Nano Letters, vol. 3, no. 4, pp. 459–463, 2003.
[85] P. Ghosh, G. Han, M. De, C. K. Kim, and V. M. Rotello,
“Gold nanoparticles in delivery applications,” Advanced Drug
Delivery Reviews, vol. 60, no. 11, pp. 1307–1315, 2008.
[86] S. Zeng, K. T. Yong, I. Roy, X. Q. Dinh, X. Yu, and F. Luan, “A
review on functionalized gold nanoparticles for biosensing
applications,” Plasmonics, vol. 6, no. 3, pp. 491–506, 2011.
[87] E. Boisselier and D. Astruc, “Gold nanoparticles in
nanomedicine: preparations, imaging, diagnostics, therapies
and toxicity,” Chemical Society Reviews, vol. 38, no. 6, pp.
1759–1782, 2009.
[88] H. L. Hsu, L. J. Teng, Y. C. Chen et al., “Flexible UV-
ozone-modified carbon nanotube electrodes for neuronal
recording,” Advanced Materials, vol. 22, no. 19, pp. 2177–
2181, 2010.
[89] E. Hirata, M. Uo, H. Takita, T. Akasaka, F. Watari, and
A. Yokoyama, “Multiwalled carbon nanotube-coating of 3D
Journal of Nanomaterials 15
collagen scaﬀolds for bone tissue engineering,” Carbon, vol.
49, no. 10, pp. 3284–3291, 2011.
[90] J. V. Veetil and K. Ye, “Tailored carbon nanotubes for tissue
engineering applications,” Biotechnology Progress, vol. 25, no.
3, pp. 709–721, 2009.
[91] S. Y. Park, D. S. Choi, H. J. Jin et al., “Polarization-controlled
diﬀerentiation of human neural stem cells using synergistic
cues from the patterns of carbon nanotube monolayer
coating,” ACS Nano, vol. 5, no. 6, pp. 4704–4711, 2011.
[92] M. Endo, S. Koyama, Y. Matsuda, T. Hayashi, and Y. A. Kim,
“Thrombogenicity and blood coagulation of a microcatheter
prepared from carbon nanotube-Nylon-based composite,”
Nano Letters, vol. 5, no. 1, pp. 101–105, 2005.
[93] H. Fan, P. Chen, R. Qi et al., “Greatly improved blood
compatibility by microscopic multiscale design of surface
architectures,” Small, vol. 5, no. 19, pp. 2144–2148, 2009.
[94] W. Tutak, M. Chhowalla, and F. Sesti, “The chemical and
physical characteristics of single-walled carbon nanotube
film impact on osteoblastic cell response,” Nanotechnology,
vol. 21, no. 31, Article ID 315102, 2010.
[95] N. A. Kotov, B. S. Shim, and J. Zhu, “Carbon nanotubes com-
posites made by the layer-by-layer assembly: from ultrastrong
materials to solar cells and devices for neural interface,”
Abstracts of Papers of the American Chemical Society, vol. 237,
2009.
[96] H. J. Lee, J. Park, O. J. Yoon et al., “Amine-modified single-
walled carbon nanotubes protect neurons from injury in a
rat stroke model,” Nature Nanotechnology, vol. 6, no. 2, pp.
121–125, 2011.
[97] M. P. Mattson, R. C. Haddon, and A. M. Rao, “Molecular
functionalization of carbon nanotubes and use as substrates
for neuronal growth,” Journal of Molecular Neuroscience, vol.
14, no. 3, pp. 175–182, 2000.
[98] S. Namgung, T. Kim, K. Y. Baik, M. Lee, J. M. Nam, and
S. Hong, “Fibronectin-carbon-nanotube hybrid nanostruc-
tures for controlled cell growth,” Small, vol. 7, no. 1, pp. 56–
61, 2011.
[99] D. Liu, C. Yi, D. Zhang, J. Zhang, andM. Yang, “Inhibition of
proliferation and diﬀerentiation of mesenchymal stem cells
by carboxylated carbon nanotubes,” ACS Nano, vol. 4, no. 4,
pp. 2185–2195, 2010.
[100] H. Hu, Y. Ni, V. Montana, R. C. Haddon, and V. Parpura,
“Chemically functionalized carbon nanotubes as substrates
for neuronal growth,”Nano Letters, vol. 4, no. 3, pp. 507–511,
2004.
[101] X. Shi, J. L. Hudson, P. P. Spicer, J. M. Tour, R. Krishnamoorti,
and A. G. Mikos, “Injectable nanocomposites of single-
walled carbon nanotubes and biodegradable polymers for
bone tissue engineering,” Biomacromolecules, vol. 7, no. 7, pp.
2237–2242, 2006.
[102] T. R. Nayak, L. Jian, L. C. Phua, H. K. Ho, Y. Ren,
and G. Pastorin, “Thin films of functionalized multiwalled
carbon nanotubes as suitable scaﬀold materials for stem cells
proliferation and bone formation,” ACS Nano, vol. 4, no. 12,
pp. 7717–7725, 2010.
[103] A. Eitan, K. Jiang, D. Dukes, R. Andrews, and L. S. Schadler,
“Surface modification of multiwalled carbon nanotubes:
toward the tailoring of the interface in polymer composites,”
Chemistry of Materials, vol. 15, no. 16, pp. 3198–3201, 2003.
[104] M. Vila, J. L. Hueso, M. Manzano et al., “Carbon nano-
tubes—mesoporous silica composites as controllable bioma-
terials,” Journal of Materials Chemistry, vol. 19, no. 41, pp.
7745–7752, 2009.
[105] B. Sitharaman, X. Shi, X. F. Walboomers et al., “In
vivo biocompatibility of ultra-short single-walled carbon
nanotube/biodegradable polymer nanocomposites for bone
tissue engineering,” Bone, vol. 43, no. 2, pp. 362–370, 2008.
[106] S. Giannona, I. Firkowska, J. Rojas-Chapana, and M. Gier-
sig, “Vertically aligned carbon nanotubes as cytocompat-
ible material for enhanced adhesion and proliferation of
osteoblast-like cells,” Journal of Nanoscience and Nanotech-
nology, vol. 7, no. 4-5, pp. 1679–1683, 2007.
[107] Z. J. Han, K. Ostrikov, C. M. Tan, B. K. Tay, and S. A. F.
Peel, “Eﬀect of hydrophilicity of carbon nanotube arrays on
the release rate and activity of recombinant human bone
morphogenetic protein-2,” Nanotechnology, vol. 22, no. 29,
Article ID 295712, 2011.
[108] M. A. Shokrgozar, F. Mottaghitalab, V. Mottaghitalab, andM.
Farokhi, “Fabrication of porous chitosan/poly(vinyl alcohol)
reinforced single-walled carbon nanotube nanocomposites
for neural tissue engineering.,” Journal of biomedical nan-
otechnology, vol. 7, no. 2, pp. 276–284, 2011.
[109] H. J. Lee, O. J. Yoon, D. H. Kim et al., “Neurite out-
growth on nanocomposite scaﬀolds synthesized from PLGA
and carboxylated carbon nanotubes,” Advanced Engineering
Materials, vol. 11, no. 12, pp. B261–B266, 2009.
[110] V. N. Mochalin, O. Shenderova, D. Ho, and Y. Gogotsi,
“The properties and applications of nanodiamonds,” Nature
Nanotechnology, vol. 7, no. 1, pp. 11–23, 2012.
[111] A. M. Schrand, H. Huang, C. Carlson et al., “Are diamond
nanoparticles cytotoxic?” Journal of Physical Chemistry B, vol.
111, no. 1, pp. 2–7, 2007.
[112] V. N. Khabashesku, J. L. Margrave, and E. V. Barrera,
“Functionalized carbon nanotubes and nanodiamonds for
engineering and biomedical applications,” Diamond and
Related Materials, vol. 14, no. 3–7, pp. 859–866, 2005.
[113] W. Wu, R. Li, X. Bian et al., “Covalently combining carbon
nanotubes with anticancer agent: preparation and antitumor
activity,” ACS Nano, vol. 3, no. 9, pp. 2740–2750, 2009.
[114] J. Chen, S. Chen, X. Zhao, L. V. Kuznetsova, S. S. Wong, and
I. Ojima, “Functionalized single-walled carbon nanotubes
as rationally designed vehicles for tumor-targeted drug
delivery,” Journal of the American Chemical Society, vol. 130,
no. 49, pp. 16778–16785, 2008.
[115] J. Rojas-Chapana, J. Troszczynska, I. Firkowska, C.
Morsczeck, and M. Giersig, “Multi-walled carbon nanotubes
for plasmid delivery into Escherichia coli cells,” Lab on a
Chip, vol. 5, no. 5, pp. 536–539, 2005.
[116] C. R. Martin and P. Kohli, “The emerging field of nanotube
biotechnology,” Nature Reviews Drug Discovery, vol. 2, no. 1,
pp. 29–37, 2003.
[117] M. S. Ladeira, V. A. Andrade, E. R. M. Gomes et al., “Highly
eﬃcient siRNA delivery system into human and murine cells
using single-wall carbon nanotubes,” Nanotechnology, vol.
21, no. 38, Article ID 385101, 2010.
[118] S. J. Son, X. Bai, and S. B. Lee, “Inorganic hollow nanopar-
ticles and nanotubes in nanomedicine. Part 1. Drug/gene
delivery applications,” Drug Discovery Today, vol. 12, no. 15-
16, pp. 650–656, 2007.
[119] R. Prakash, S. Washburn, R. Superfine, R. E. Cheney, and M.
R. Falvo, “Visualization of individual carbon nanotubes with
fluorescence microscopy using conventional fluorophores,”
Applied Physics Letters, vol. 83, no. 6, pp. 1219–1221, 2003.
[120] M. Ritschel, A. Leonhardt, D. Elefant, S. Oswald, and B.
Bu¨chner, “Rhenium-catalyzed growth carbon nanotubes,”
Journal of Physical Chemistry C, vol. 111, no. 24, pp. 8414–
8417, 2007.
16 Journal of Nanomaterials
[121] R. Klingeler, S. Hampel, and B. Bu¨chner, “Carbon nanotube
based biomedical agents for heating, temperature sensoring
and drug delivery,” International Journal of Hyperthermia,
vol. 24, no. 6, pp. 496–505, 2008.
[122] T. A. Hilder and J. M. Hill, “Modeling the loading and
unloading of drugs into nanotubes,” Small, vol. 5, no. 3, pp.
300–308, 2009.
[123] Q. Mu, D. L. Broughton, and B. Yan, “Endosomal leakage
and nuclear translocation of multiwalled carbon nanotubes:
developing a model for cell uptake,” Nano Letters, vol. 9, no.
12, pp. 4370–4375, 2009.
[124] A. Nunes, N. Amsharov, C. Guo et al., “Hybrid polymer-
grafted multiwalled carbon nanotubes for in vitro gene
delivery,” Small, vol. 6, no. 20, pp. 2281–2291, 2010.
[125] H. K. Moon, S. H. Lee, and H. C. Choi, “In vivo near-
infrared mediated tumor destruction by photothermal eﬀect
of carbon nanotubes,” ACS Nano, vol. 3, no. 11, pp. 3707–
3713, 2009.
[126] A. Joshi, S. Punyani, S. S. Bale, H. Yang, T. Borca-Tasciuc, and
R. S. Kane, “Nanotube-assisted protein deactivation,” Nature
Nanotechnology, vol. 3, no. 1, pp. 41–45, 2008.
[127] S. Ghosh, S. Dutta, E. Gomes et al., “Increased heating
eﬃciency and selective thermal ablation of malignant tissue
with DNA-encased multiwalled carbon nanotubes,” ACS
Nano, vol. 3, no. 9, pp. 2667–2673, 2009.
[128] B. Kang, Y. Dai, S. Chang, and D. Chen, “Explosion of single-
walled carbon nanotubes in suspension induced by a large
photoacoustic eﬀect,” Carbon, vol. 46, no. 6, pp. 978–981,
2008.
[129] Y. Lee and K. E. Geckeler, “Carbon nanotubes in the bio-
logical interphase: the relevance of noncovalence,” Advanced
Materials, vol. 22, no. 36, pp. 4076–4083, 2010.
[130] P. Ghafari, C. H. St-Denis, M. E. Power et al., “Impact of
carbon nanotubes on the ingestion and digestion of bacteria
by ciliated protozoa,” Nature Nanotechnology, vol. 3, no. 6,
pp. 347–351, 2008.
[131] Z. J. Han, I. Levchenko, S. Kumar et al., “Plasma nanofabri-
cation and nanomaterials safety,” Journal of Physics D, vol. 44,
no. 17, Article ID 174019, 2011.
[132] A. Huczko, “Synthesis of aligned carbon nanotubes,” Applied
Physics A, vol. 74, no. 5, pp. 617–638, 2002.
[133] D. Elgrabli, M. Floriani, S. Abella-Gallart et al., “Biodistribu-
tion and clearance of instilled carbon nanotubes in rat lung,”
Particle and Fibre Toxicology, vol. 5, article no. 20, 2008.
[134] Y. Usui, K. Aoki, N. Narita et al., “Carbon nanotubes
with high bone-tissue compatibility and bone-formation
acceleration eﬀects,” Small, vol. 4, no. 2, pp. 240–246, 2008.
[135] J. P. Ryman-Rasmussen, M. F. Cesta, A. R. Brody et al.,
“Inhaled carbon nanotubes reach the subpleural tissue in
mice,” Nature Nanotechnology, vol. 4, no. 11, pp. 747–751,
2009.
[136] S. Iijima, “Helical microtubules of graphitic carbon,” Nature,
vol. 354, no. 6348, pp. 56–58, 1991.
[137] Innovative Research and Products Incorporated, “Produc-
tion and applications of carbon nanotubes, carbon nano-
fibres, fullerenes, graphene and nanodiamonds: a global
technology survey and market analysis,” 2011, http://www
.innoresearch.net/report summary.aspx?id=77&pg531&
rcd=et-113&pd=2/1/2011.
[138] C. Buzea, I. I. Pacheco, and K. Robbie, “Nanomaterials and
nanoparticles: sources and toxicity,” Biointerphases, vol. 2, no.
4, pp. MR17–MR71, 2007.
[139] X. Deng, G. Jia, H. Wang et al., “Translocation and fate of
multi-walled carbon nanotubes in vivo,” Carbon, vol. 45, no.
7, pp. 1419–1424, 2007.
[140] M. L. Schipper, N. Nakayama-Ratchford, C. R. Davis et al.,
“A pilot toxicology study of single-walled carbon nanotubes
in a small sample of mice,”Nature Nanotechnology, vol. 3, no.
4, pp. 216–221, 2008.
[141] G. M. Mutlu, G. R. S. Budinger, A. A. Green et al.,
“Biocompatible nanoscale dispersion of single-walled carbon
nanotubes minimizes in vivo pulmonary toxicity,” Nano
Letters, vol. 10, no. 5, pp. 1664–1670, 2010.
[142] C. A. Poland, R. Duﬃn, I. Kinloch et al., “Carbon nanotubes
introduced into the abdominal cavity of mice show asbestos-
like pathogenicity in a pilot study,” Nature Nanotechnology,
vol. 3, no. 7, pp. 423–428, 2008.
[143] F. Zhao, Y. Zhao, Y. Liu, X. Chang, C. Chen, and Y. Zhao,
“Cellular uptake, intracellular traﬃcking, and cytotoxicity of
nanomaterials,” Small, vol. 7, no. 10, pp. 1322–1337, 2011.
[144] F. Zhou, D. Xing, B. Wu, S. Wu, Z. Ou, and W. R.
Chen, “New insights of transmembranal mechanism and
subcellular localization of noncovalently modified single-
walled carbon nanotubes,” Nano Letters, vol. 10, no. 5, pp.
1677–1681, 2010.
[145] D. Pantarotto, J. P. Briand, M. Prato, and A. Bianco,
“Translocation of bioactive peptides across cell membranes
by carbon nanotubes,” Chemical Communications, vol. 10,
no. 1, pp. 16–17, 2004.
[146] S. Liu, L. Wei, L. Hao et al., “Sharper and faster “Nano darts”
kill more bacteria: a study of antibacterial activity of individ-
ually dispersed pristine single-walled carbon nanotube,” ACS
Nano, vol. 3, no. 12, pp. 3891–3902, 2009.
[147] S. Pogodin and V. A. Baulin, “Can a carbon nanotube pierce
through a phospholipid bilayer?” ACS Nano, vol. 4, no. 9, pp.
5293–5300, 2010.
[148] M. Wang, S. Yu, C. Wang, and J. Kong, “Tracking the endo-
cytic pathway of recombinant protein toxin delivered by
multiwalled carbon nanotubes,” ACS Nano, vol. 4, no. 11, pp.
6483–6490, 2010.
[149] X. Shi, A. Von Dem Bussche, R. H. Hurt, A. B. Kane, and H.
Gao, “Cell entry of one-dimensional nanomaterials occurs by
tip recognition and rotation,” Nature Nanotechnology, vol. 6,
no. 11, pp. 714–719, 2011.
[150] A. Antonelli, S. Serafini, M. Menotta et al., “Improved
cellular uptake of functionalized single-walled carbon nan-
otubes,” Nanotechnology, vol. 21, no. 42, Article ID 425101,
2010.
[151] Q. Mu, D. L. Broughton, and B. Yan, “Endosomal leakage
and nuclear translocation of multiwalled carbon nanotubes:
developing a model for cell uptake,” Nano Letters, vol. 9, no.
12, pp. 4370–4375, 2009.
[152] F. Zhou, D. Xing, B.Wu, S. Wu, Z. Ou, andW. R. Chen, “New
insights of transmembranal mechanism and subcellular
localization of noncovalently modified single-walled carbon
nanotubes,”Nano Letters, vol. 10, no. 5, pp. 1677–1681, 2010.
[153] K. Kostarelos, L. Lacerda, G. Pastorin et al., “Cellular uptake
of functionalized carbon nanotubes is independent of func-
tional group and cell type,”Nature Nanotechnology, vol. 2, no.
2, pp. 108–113, 2007.
[154] M. F. Serag, N. Kaji, E. Venturelli et al., “Functional platform
for controlled subcellular distribution of carbon nanotubes,”
ACS Nano, vol. 5, no. 11, pp. 9264–9270, 2011.
Journal of Nanomaterials 17
[155] Y. Yao, L. K. L. Falk, R. E. Morjan, O. A. Nerushev, and E. E.
B. Campbell, “Cross-sectional TEM investigation of nickel-
catalysed carbon nanotube films grown by plasma-enhanced
CVD,” Journal of Microscopy, vol. 219, no. 2, pp. 69–75, 2005.
[156] L. Wang, S. Luanpitpong, V. Castranova et al., “Carbon nan-
otubes induce malignant transformation and tumorigenesis
of human lung epithelial cells,” Nano Letters, vol. 11, no. 7,
pp. 2796–2803, 2011.
[157] M. J. Osmond-McLeod, C. A. Poland, F. Murphy et al.,
“Durability and inflammogenic impact of carbon nanotubes
compared with asbestos fibres,” Particle and Fibre Toxicology,
vol. 8, article no. 15, 2011.
[158] Y. Zhang, S. F. Ali, E. Dervishi et al., “Cytotoxicity eﬀects
of graphene and single-wall carbon nanotubes in neural
phaeochromocytoma-derived pc12 cells,” ACS Nano, vol. 4,
no. 6, pp. 3181–3186, 2010.
[159] J. Paloma¨ki, E. Va¨lima¨ki, J. Sund et al., “Long, needle-
like carbon nanotubes and asbestos activate the NLRP3
inflammasome through a similar mechanism,” ACS Nano,
vol. 5, no. 9, pp. 6861–6870, 2011.
[160] N. M. Schaeublin, L. K. Braydich-Stolle, A. M. Schrand et al.,
“Surface charge of gold nanoparticles mediates mechanism
of toxicity,” Nanoscale, vol. 3, no. 2, pp. 410–420, 2011.
[161] J. Muller, I. Decordier, P. H. Hoet et al., “Clastogenic and
aneugenic eﬀects of multi-wall carbon nanotubes in epithe-
lial cells,” Carcinogenesis, vol. 29, no. 2, pp. 427–433, 2008.
[162] K. Kostarelos, A. Bianco, and M. Prato, “Promises, facts and
challenges for carbon nanotubes in imaging and therapeu-
tics,” Nature Nanotechnology, vol. 4, no. 10, pp. 627–633,
2009.
[163] X. Wang, T. Xia, S. Addo Ntim et al., “Dispersal state of
multiwalled carbon nanotubes elicits profibrogenic cellular
responses that correlate with fibrogenesis biomarkers and
fibrosis in the murine lung,” ACS Nano, vol. 5, no. 12, pp.
9772–9787, 2011.
[164] J. G. Li, W. X. Li, J. Y. Xu et al., “Comparative study of patho-
logical lesions induced by multiwalled carbon nanotubes in
lungs of mice by intratracheal instillation and inhalation,”
Environmental Toxicology, vol. 22, no. 4, pp. 415–421, 2007.
[165] Y. W. Chun, W. Wang, J. Choi et al., “Control of macrophage
responses on hydrophobic and hydrophilic carbon nanos-
tructures,” Carbon, vol. 49, no. 6, pp. 2092–2103, 2011.
[166] G. Cellot, L. Ballerini, M. Prato, and A. Bianco, “Neurons are
able to internalize soluble carbon nanotubes: new opportuni-
ties or old risks?” Small, vol. 6, no. 23, pp. 2630–2633, 2010.
[167] R. Singh, D. Pantarotto, L. Lacerda et al., “Tissue biodistribu-
tion and blood clearance rates of intravenously administered
carbon nanotube radiotracers,” Proceedings of the National
Academy of Sciences of the United States of America, vol. 103,
no. 9, pp. 3357–3362, 2006.
[168] B. Belgorodsky, E. Drug, L. Fadeev, N. Hendler, E.Mentovich,
and M. Gozin, “Mucin complexes of nanomaterials: first
biochemical encounter,” Small, vol. 6, no. 2, pp. 262–269,
2010.
[169] A. Pietroiusti, M. Massimiani, I. Fenoglio et al., “Low doses
of pristine and oxidized single-wall carbon nanotubes aﬀect
mammalian embryonic development,” ACS Nano, vol. 5, no.
6, pp. 4624–4633, 2011.
[170] B. D. Holt, P. A. Short, A. D. Rape, Y. L. Wang, M. F.
Islam, and K. N. Dahl, “Carbon nanotubes reorganize actin
structures in cells and ex Vivo,” ACS Nano, vol. 4, no. 8, pp.
4872–4878, 2010.
[171] L. A. Mitchell, J. Gao, R. V. Wal, A. Gigliotti, S. W. Burchiel,
and J. D. McDonald, “Pulmonary and systemic immune
response to inhaled multiwalled carbon nanotubes,” Toxico-
logical Sciences, vol. 100, no. 1, pp. 203–214, 2007.
[172] L. A.Mitchell, F. T. Lauer, S.W. Burchiel, and J. D.McDonald,
“Mechanisms for how inhaledmultiwalled carbon nanotubes
suppress systemic immune function in mice,” Nature Nan-
otechnology, vol. 4, no. 7, pp. 451–456, 2009.
[173] Y. Bai, Y. Zhang, J. Zhang et al., “Repeated administrations of
carbon nanotubes inmalemice cause reversible testis damage
without aﬀecting fertility,” Nature Nanotechnology, vol. 5, no.
9, pp. 683–689, 2010.
[174] C. Gaillard, G. Celiot, S. Li et al., “Carbon nanotubes car-
rying cell-adhesion peptides do not interfere with neuronal
functionality,” Advanced Materials, vol. 21, no. 28, pp. 2903–
2908, 2009.
[175] E. B. Malarkey, R. C. Reyes, B. Zhao, R. C. Haddon, and
V. Parpura, “Water soluble single-walled carbon nanotubes
inhibit stimulated endocytosis in neurons,” Nano Letters, vol.
8, no. 10, pp. 3538–3542, 2008.
[176] X. Shi, B. Sitharaman, Q. P. Pham et al., “In vitro cytotoxicity
of single-walled carbon nanotube/biodegradable polymer
nanocomposites,” Journal of Biomedical Materials Research A,
vol. 86, no. 3, pp. 813–823, 2008.
[177] B. L. Allen, P. D. Kichambare, P. Gou et al., “Biodegradation
of single-walled carbon nanotubes through enzymatic catal-
ysis,” Nano Letters, vol. 8, no. 11, pp. 3899–3903, 2008.
[178] V. E. Kagan, N. V. Konduru, W. Feng et al., “Carbon nan-
otubes degraded by neutrophil myeloperoxidase induce less
pulmonary inflammation,” Nature Nanotechnology, vol. 5,
no. 5, pp. 354–359, 2010.
[179] S. V. Morozov, K. S. Novoselov, and A. K. Geim, “Electron
transport in graphene,” Physics-Uspekhi, vol. 51, no. 7, pp.
727–748, 2008.
[180] B. Rosenstein, M. Lewkowicz, H. C. Kao, and Y. Korniyenko,
“Ballistic transport in graphene beyond linear response,”
Physical Review B, vol. 81, no. 4, Article ID 041416, 2010.
[181] C. Liu, Z. Yu, D. Neﬀ, A. Zhamu, and B. Z. Jang, “Graphene-
based supercapacitor with an ultrahigh energy density,”Nano
Letters, vol. 10, no. 12, pp. 4863–4868, 2010.
[182] B. Chitara, L. S. Panchakarla, S. B. Krupanidhi, and C. N.
R. Rao, “Infrared photodetectors based on reduced graphene
oxide and graphene nanoribbons,” Advanced Materials, vol.
23, no. 45, pp. 5419–5424, 2011.
[183] Q. Zeng, J. Cheng, L. Tang et al., “Self-assembled graphene-
enzyme hierarchical nanostructures for electrochemical
biosensing,” Advanced Functional Materials, vol. 20, no. 19,
pp. 3366–3372, 2010.
[184] S. K. Saha, M. Baskey, and D. Majumdar, “Graphene quan-
tum sheets: a new material for spintronic applications,”
Advanced Materials, vol. 22, no. 48, pp. 5531–5536, 2010.
[185] J. R. Miller, R. A. Outlaw, and B. C. Holloway, “Graphene
double-layer capacitor with ac line-filtering performance,”
Science, vol. 329, no. 5999, pp. 1637–1639, 2010.
[186] M. S. Lundstrom, “Graphene: the long and winding road,”
Nature Materials, vol. 10, no. 8, pp. 566–567, 2011.
[187] X. Ling, L. Xie, Y. Fang et al., “Can graphene be used as a
substrate for Raman enhancement?”Nano Letters, vol. 10, no.
2, pp. 553–561, 2010.
[188] A. E. Rider, S. Kumar, S. A. Furman, and K. K. Ostrikov,
“Self-organized Au nanoarrays on vertical graphenes: an
advanced three-dimensional sensing platform,” Chemical
Communications, vol. 48, no. 21, pp. 2659–2661, 2012.
[189] L. Wu, H. S. Chu, W. S. Koh, and E. P. Li, “Highly sensitive
graphene biosensors based on surface plasmon resonance.,”
Optics express, vol. 18, no. 14, pp. 14395–14400, 2010.
18 Journal of Nanomaterials
[190] X. Ling and J. Zhang, “Interference phenomenon in
graphene-enhanced Raman scattering,” Journal of Physical
Chemistry C, vol. 115, no. 6, pp. 2835–2840, 2011.
[191] D. H. Seo, S. Kumar, and K. Ostrikov, “Control of morphol-
ogy and electrical properties of self-organized graphenes in a
plasma,” Carbon, vol. 49, no. 13, pp. 4331–4339, 2011.
[192] K. Yang, S. Zhang, G. Zhang, X. Sun, S. T. Lee, and Z.
Liu, “Graphene in mice: ultrahigh in vivo tumor uptake and
eﬃcient photothermal therapy,” Nano Letters, vol. 10, no. 9,
pp. 3318–3323, 2010.
[193] L. Zhang, Z. Lu, Q. Zhao, J. Huang, H. Shen, and Z. Zhang,
“Enhanced chemotherapy eﬃcacy by sequential delivery of
siRNA and anticancer drugs using PEI-grafted graphene
oxide,” Small, vol. 7, no. 4, pp. 460–464, 2011.
[194] Y. Ohno, K. Maehashi, and K. Matsumoto, “Label-free
biosensors based on aptamer-modified graphene field-eﬀect
transistors,” Journal of the American Chemical Society, vol.
132, no. 51, pp. 18012–18013, 2010.
[195] W. Hong, H. Bai, Y. Xu, Z. Yao, Z. Gu, and G. Shi, “Prepa-
ration of gold nanoparticle/graphene composites with con-
trolled weight contents and their application in biosensors,”
Journal of Physical Chemistry C, vol. 114, no. 4, pp. 1822–
1826, 2010.
[196] H. Chang, L. Tang, Y. Wang, J. Jiang, and J. Li, “Graphene
fluorescence resonance energy transfer aptasensor for the
thrombin detection,” Analytical Chemistry, vol. 82, no. 6, pp.
2341–2346, 2010.
[197] Y. Wan, Z. Lin, D. Zhang, Y. Wang, and B. Hou, “Impedi-
metric immunosensor doped with reduced graphene sheets
fabricated by controllable electrodeposition for the non-
labelled detection of bacteria,” Biosensors and Bioelectronics,
vol. 26, no. 5, pp. 1959–1964, 2011.
[198] T. Kuila, S. Bose, P. Khanra, A. K. Mishra, N. H. Kim, and
J. H. Lee, “Recent advances in graphene-based biosensors,”
Biosensors and Bioelectronics, vol. 26, no. 12, pp. 4637–4648,
2011.
[199] Y. A. Akimov, K. Ostrikov, and E. P. Li, “Surface plasmon
enhancement of optical absorption in thin-film silicon solar
cells,” Plasmonics, vol. 4, no. 2, pp. 107–113, 2009.
[200] I. Heller, S. Chatoor, J. Ma¨nnik, M. A. G. Zevenbergen, C.
Dekker, and S. G. Lemay, “Influence of electrolyte com-
position on liquid-gated carbon nanotube and graphene
transistors,” Journal of the American Chemical Society, vol.
132, no. 48, pp. 17149–17156, 2010.
[201] H. Ohno, D. Takagi, K. Yamada, S. Chiashi, A. Tokura, and Y.
Homma, “Growth of vertically aligned single-walled carbon
nanotubes on alumina and sapphire substrates,” Japanese
Journal of Applied Physics, vol. 47, no. 4, pp. 1956–1960, 2008.
[202] Y. Zhang, J. Zhang, X. Huang, X. Zhou, H. Wu, and S. Guo,
“Assembly of graphene oxide-enzyme conjugates through
hydrophobic interaction,” Small, vol. 8, no. 1, pp. 154–159,
2012.
[203] J. S. Czarnecki, K. Lafdi, and P. A. Tsonis, “A novel approach
to control growth, orientation, and shape of human
osteoblasts,” Tissue Engineering A, vol. 14, no. 2, pp. 255–265,
2008.
[204] H. Pandey, V. Parashar, R. Parashar, R. Prakash, P. W.
Ramteke, and A. C. Pandey, “Controlled drug release char-
acteristics and enhanced antibacterial eﬀect of graphene
nanosheets containing gentamicin sulfate,” Nanoscale, vol. 3,
no. 10, pp. 4104–4108, 2011.
[205] V. K. Rana, M. C. Choi, J. Y. Kong et al., “Synthesis and
drug-delivery behavior of chitosan-functionalized graphene
oxide hybrid nanosheets,” Macromolecular Materials and
Engineering, vol. 296, no. 2, pp. 131–140, 2011.
[206] X. M. Sun, Z. Liu, K. Welsher et al., “Nano-graphene oxide
for cellular imaging and drug delivery,” Nano Research, vol.
1, no. 3, pp. 203–212, 2008.
[207] L. Zhang, J. Xia, Q. Zhao, L. Liu, and Z. Zhang, “Functional
graphene oxide as a nanocarrier for controlled loading and
targeted delivery of mixed anticancer drugs,” Small, vol. 6,
no. 4, pp. 537–544, 2010.
[208] W. Zhang, Z. Guo, D. Huang, Z. Liu, X. Guo, and H.
Zhong, “Synergistic eﬀect of chemo-photothermal therapy
using PEGylated graphene oxide,” Biomaterials, vol. 32, no.
33, pp. 8555–8561, 2011.
[209] B. Tian, C. Wang, S. Zhang, L. Feng, and Z. Liu, “Photother-
mally enhanced photodynamic therapy delivered by nano-
graphene oxide,” ACS Nano, vol. 5, no. 9, pp. 7000–7009,
2011.
[210] C. Dekker, “Solid-state nanopores,” Nature Nanotechnology,
vol. 2, no. 4, pp. 209–215, 2007.
[211] S. K. Min, W. Y. Kim, Y. Cho, and K. S. Kim, “Fast DNA
sequencing with a graphene-based nanochannel device,”
Nature Nanotechnology, vol. 6, no. 3, pp. 162–165, 2011.
[212] Y. Cho, S. K. Min, W. Y. Kim, and K. S. Kim, “The origin
of dips for the graphene-based DNA sequencing device,”
Physical Chemistry Chemical Physics, vol. 13, no. 32, pp.
14293–14296, 2011.
[213] C. A. Merchant, K. Healy, M. Wanunu et al., “DNA translo-
cation through graphene nanopores,” Nano Letters, vol. 10,
no. 8, pp. 2915–2921, 2010.
[214] S. S. Kelkar and T. M. Reineke, “Theranostics: combining
imaging and therapy,” Bioconjugate Chemistry, vol. 22, no. 10,
pp. 1879–1903, 2011.
[215] K. Yang, J. Wan, S. Zhang, Y. Zhang, S. T. Lee, and Z. Liu,
“In vivo pharmacokinetics, long-term biodistribution, and
toxicology of pegylated graphene in mice,” ACS Nano, vol.
5, no. 1, pp. 516–522, 2011.
[216] O. Akhavan and E. Ghaderi, “Toxicity of graphene and
graphene oxide nanowalls against bacteria,” ACS Nano, vol.
4, no. 10, pp. 5731–5736, 2010.
[217] Y. Chang, S. T. Yang, J. H. Liu et al., “In vitro toxicity
evaluation of graphene oxide on A549 cells,” Toxicology
Letters, vol. 200, no. 3, pp. 201–210, 2011.
[218] K. M. Garza, K. F. Soto, and L. E. Murr, “Cytotoxicity and
reactive oxygen species generation from aggregated carbon
and carbonaceous nanoparticulate materials,” International
Journal of Nanomedicine, vol. 3, no. 1, pp. 83–94, 2008.
[219] K.-H. Liao, Y. S. Lin, C. W. MacOsko, and C. L. Haynes,
“Cytotoxicity of graphene oxide and graphene in human
erythrocytes and skin fibroblasts,” ACS Applied Materials and
Interfaces, vol. 3, no. 7, pp. 2607–2615, 2011.
[220] M. Pumera, “Graphene in biosensing,” Materials Today, vol.
14, no. 7-8, pp. 308–315, 2011.
[221] S. K. Singh, M. K. Singh, M. K. Nayak, S. Kumari, J. J. Gra´cio,
and D. Dash, “Characterization of graphene oxide by flow
cytometry and assessment of its cellular toxicity.,” Journal of
biomedical nanotechnology, vol. 7, no. 1, pp. 30–31, 2011.
[222] X. Zhang, J. Yin, C. Peng et al., “Distribution and biocom-
patibility studies of graphene oxide in mice after intravenous
administration,” Carbon, vol. 49, no. 3, pp. 986–995, 2011.
[223] L. Yan, F. Zhao, S. Li, Z. Hu, and Y. Zhao, “Low-toxic
and safe nanomaterials by surface-chemical design, carbon
nanotubes, fullerenes, metallofullerenes, and graphenes,”
Nanoscale, vol. 3, no. 2, pp. 362–382, 2011.
Journal of Nanomaterials 19
[224] A. Sasidharan, L. S. Panchakarla, P. Chandran et al., “Dif-
ferential nano-bio interactions and toxicity eﬀects of pristine
versus functionalized graphene.,” Nanoscale, vol. 3, no. 6, pp.
2461–2464, 2011.
[225] K. Wang, J. Ruan, H. Song et al., “Biocompatibility of
graphene oxide,” Nanoscale Research Letters, vol. 6, no. 1, pp.
1–8, 2011.
[226] S. H. Yang, T. Lee, E. Seo, E. H. Ko, I. S. Choi, and B.-
S. Kim, “Interfacing living yeast cells with graphene oxide
nanosheaths,” Macromolecular Bioscience, vol. 12, no. 1, pp.
61–66, 2012.
[227] K. S. Novoselov, A. K. Geim, S. V. Morozov et al., “Electric
field in atomically thin carbon films,” Science, vol. 306, no.
5696, pp. 666–669, 2004.
[228] K. Liu, J. J. Zhang, F. F. Cheng, T. T. Zheng, C. Wang, and J.
J. Zhu, “Green and facile synthesis of highly biocompatible
graphene nanosheets and its application for cellular imaging
and drug delivery,” Journal ofMaterials Chemistry, vol. 21, no.
32, pp. 12034–12040, 2011.
[229] S. Alwarappan, A. Erdem, C. Liu, and C. Z. Li, “Probing
the electrochemical properties of graphene nanosheets for
biosensing applications,” Journal of Physical Chemistry C, vol.
113, no. 20, pp. 8853–8857, 2009.
[230] A. N. Obraztsov, E. A. Obraztsova, A. V. Tyurnina, and A.
A. Zolotukhin, “Chemical vapor deposition of thin graphite
films of nanometer thickness,” Carbon, vol. 45, no. 10, pp.
2017–2021, 2007.
[231] Q. Yu, J. Lian, S. Siriponglert, H. Li, Y. P. Chen, and S. S.
Pei, “Graphene segregated on Ni surfaces and transferred to
insulators,” Applied Physics Letters, vol. 93, no. 11, Article ID
113103, 2008.
[232] Y. Q. Wu, P. D. Ye, M. A. Capano et al., “Top-gated graphene
field-eﬀect-transistors formed by decomposition of SiC,”
Applied Physics Letters, vol. 92, no. 9, Article ID 092102, 2008.
[233] A. N. Obraztsov, A. A. Zolotukhin, A. O. Ustinov, A. P.
Volkov, Y. Svirko, and K. Jefimovs, “DC discharge plasma
studies for nanostructured carbon CVD,” Diamond and
Related Materials, vol. 12, no. 3–7, pp. 917–920, 2003.
[234] M. Zhu, J. Wang, B. C. Holloway et al., “A mechanism for
carbon nanosheet formation,” Carbon, vol. 45, no. 11, pp.
2229–2234, 2007.
[235] K. S. Subrahmanyam, L. S. Panchakarla, A. Govindaraj, and
C. N. R. Rao, “Simple method of preparing graphene flakes
by an arc-discharge method,” Journal of Physical Chemistry C,
vol. 113, no. 11, pp. 4257–4259, 2009.
[236] L. Jiao, L. Zhang, X. Wang, G. Diankov, and H. Dai, “Narrow
graphene nanoribbons from carbon nanotubes,” Nature, vol.
458, no. 7240, pp. 877–880, 2009.
[237] D. V. Kosynkin, A. L. Higginbotham, A. Sinitskii et al.,
“Longitudinal unzipping of carbon nanotubes to form
graphene nanoribbons,” Nature, vol. 458, no. 7240, pp. 872–
876, 2009.
[238] W. Choi, I. Lahiri, R. Seelaboyina, and Y. S. Kang, “Synthesis
of graphene and its applications: a review,” Critical Reviews
in Solid State and Materials Sciences, vol. 35, no. 1, pp. 52–71,
2010.
[239] H. Jiang, “Chemical preparation of graphene-based nano-
materials and their applications in chemical and biological
sensors,” Small, vol. 7, no. 17, pp. 2413–2427, 2011.
[240] A. E. Rider and K. Ostrikov, “Assembly and self-organization
of nanomaterials,” in Plasma Processing of Nanomaterials, R.
M. Sankaran, Ed., pp. 371–392, CRC Press, Boca Raton, Fla,
USA, 2011.
[241] D. H. Seo, S. Kumar, and K. Ostrikov, “Thinning vertical
graphenes, tuning electrical response: from semiconducting
to metallic,” Journal of Materials Chemistry, vol. 21, no. 41,
pp. 16339–16343, 2011.
Submit your manuscripts at
http://www.hindawi.com
Scientifica
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Corrosion
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Polymer Science
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Ceramics
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Composites
Journal of
Nanoparticles
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
International Journal of
Biomaterials
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Nanoscience
Journal of
Textiles
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Journal of
Nanotechnology
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal of
Crystallography
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
The Scientific 
World Journal
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Coatings
Journal of
Advances in 
Materials Science and Engineering
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Smart Materials 
Research
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Metallurgy
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
BioMed 
Research International
Materials
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
N
an
om
at
er
ia
ls
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal ofNanomaterials
